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Summary 
Rhodococci represent an important genus of industrial interest, both because of 
their role in bioremediation and biocatalysis, as well as for their potential as 
producers of natural products. In this context, the genome sequencing of the 
biphenyl-degrading soil bacterium Rhodococcus jostii RHA1 represents the first 
attempt to harness the biosynthetic metabolic potential of the genus Rhodococcus, by 
enabling the systematic exploration of its natural product-producing capabilities. 
The genome of R. jostii RHA1 contains 23 secondary metabolite gene clusters, all 
considered to be orphan with respect to their product, including two clusters 
putatively involved in siderophore biosynthesis. In this study, the isolation, 
structural characterization and genetic analysis of the biosynthetic origin of 
rhodochelin, a unique mixed-type catecholate-hydroxamate siderophore isolated 
from R. jostii RHA1, which represents the first characterized NRPS-derived natural 
product of the strain, is reported. Structure elucidation of rhodochelin was 
accomplished via MSn- and NMR-analysis and revealed the tetrapeptide to contain 
an unusual ester bond between an L-δ-N-formyl-δ-N-hydroxyornithine (L-fhOrn) 
moiety and the side chain of a threonine residue. Bioinformatic analysis of the R. 
jostii RHA1 genome revealed the enzymes responsible for siderophore biosynthesis 
to be encoded in three distant NRPS gene clusters. Single gene deletions within the 
three putative biosynthetic gene clusters abolished rhodochelin production, proving 
that the ORFs responsible for rhodochelin biosynthesis are located in different 
chromosomal loci. Biochemical characterization of the monooxygenase Rmo and the 
formyltransferase Rft established a route for the biosynthesis of the non-
proteinogenic amino acid L-fhOrn, prior to its incorporation into the peptide 
scaffold by the NRPS-assembly line. The insights gained from the structural and 
functional characterization of rhodochelin, together with the genetic and 
biochemical characterization of the respective biosynthetic gene clusters, allowed 
the proposal of a biosynthetic model for rhodochelin assembly. Finally, the efficient 
and, in this work, first reported cross-talk between three distantly located secondary 
metabolite gene clusters provides deep insights into natural product biosynthesis 
that may facilitate future attempts to isolate new natural products. 
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Zusammenfassung 
Bei den Rhodococci handelt es sich um ein bakterielles Genus von industrieller 
Relevanz, welches bei der biologischen Dekontaminierung und Biokatalyse zum 
Einsatz kommt und dessen Mitglieder großes Potential als Produzenten neuer 
Naturstoffe zeigen. In diesem Zusammenhang stellt die Genomsequenzierung des 
Biphenyl-abbauenden Bodenbakteriums Rhodococcus jostii RHA1 den ersten Versuch 
dar das biosynthetische Potential des Genus Rhodococcus auszuloten, da das 
Vorliegen der kompletten Genomsequenz die systematische Erforschung der 
Naturstoffproduktion erlaubt. Das Genom von R. jostii RHA1 enthält 23 
Sekundärmetabolit-Gencluster, darunter zwei putative Siderophor-
Biosynthesecluster, wobei alle als „orphan“ zu bezeichnen sind, da ihnen kein 
konkretes Produkt zugeordnet werden kann. In der vorliegenden Arbeit soll die 
Isolierung, strukturelle Charakterisierung und genetische sowie biochemische 
Analyse des biosynthetischen Ursprungs von Rhodochelin, dem ersten aus R. jostii 
RHA1 isolierten „mixed-type“ Catechol-Hydroxamat Siderophore, welches das 
erste charakterisierte NRPS-abhängige Naturprodukt dieses Stamms darstellt, 
behandelt werden. Zur Strukturaufklärung von Rhodochelin wurden sowohl MSn- 
als auch NMR-Studien durchgeführt, welche ergaben, dass es sich um ein 
Tetrapeptid handelt, das eine ungewöhnliche Esterbindung zwischen einem L-δ-N-
Formyl-δ-N-hydroxy-Ornithinrest (L-fhOrn) und einer Threoninseitenkette enthält. 
Eine bioinformatische Analyse des R. jostii RHA1 Genoms zeigte, dass die für die 
Biosynthese verantwortlichen Gene in drei unterschiedlichen, voneinander weit 
entfernten NRPS-Genclustern lokalisiert sind. Durch Einzelgendeletionen in den 
jeweiligen Clustern, durch welche die Rhodochelinproduktion komplett 
aufgehoben wurde, konnte eindeutig gezeigt werden, dass die für die Rhodochelin-
Biosynthese verantwortlichen Gencluster in drei unterschiedlichen Loci auf dem R. 
jostii RHA1 Chromosom vorliegen. Durch die biochemische Charakterisierung der 
Monooxygenase Rmo und der Formyltransferase Rft konnte ein Biosyntheseweg für 
die nicht-proteinogene Aminosäure L-fhOrn etabliert werden, welche anschließend 
durch die NRPS-Maschinerie in das Peptidgerüst eingebaut wird. Mit Hilfe der 
durch die strukturelle und funktionelle Charakterisierung von Rhodochelin, sowie 
der genetischen und biochemischen Analysen der verantwortlichen Biosynthese-
Gencluster gewonnen Einsichten, konnte eine Biosyntheseroute für das Siderophor 
Rhodochelin postuliert werden. Die aus der vorliegenden Arbeit gewonnenen 
Erkenntnisse bezüglich des effizienten und vormals unbekannten „cross-talks“ 
zwischen drei weit voneinander entfernten Sekundärmetabolit-Genclustern 
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erlauben neue Einblicke in die Organisation des bakteriellen 
Sekundärmetabolismus und tragen zu einem besseren Verständnis der Biosynthese 
von Naturstoffen bei. Des Weiteren können die gewonnenen Ergebnisse als 
Ausgangspunkt für eine zukünftige Isolierung neuer Naturstoffe dienen. 
 
  
Chapter 1 
Introduction 
Introduction 
 2 
1.1 Siderophore-based iron acquisition 
1.1.1 The biological role of iron 
Under physiological conditions, iron exists in two redox forms: Fe2+ (ferrous iron) 
and Fe3+ (ferric iron), easily convertible into each other under acidic or basic 
conditions [E0acid (Fe2+/Fe3+) = 0.771 V, E0basic (Fe2+/Fe3+) = -0.690 V]. These redox 
properties put the element in a central and extremely versatile position for almost 
the entire spectrum of biological processes needing a redox potential between -0.5 
and 0.6 V.1 In fact, being the fourth most common element on Earth (and the second 
most common metal), iron takes part as an essential cofactor in many enzymes of 
cellular metabolism (photosynthesis, Krebs cycle, respiratory chain, nitrogen 
fixation and methanogenesis among others) since the early days of anaerobic life on 
the planet. Under aerobic conditions, soluble Fe(II) spontaneously oxidizes to Fe(III) 
which, in the presence of oxygen, water and at neutral pH, forms insoluble ferric 
oxide hydrate complexes, leading to a free Fe(III) concentration of only up to 10-18 M.2 
In addition, in the presence of molecular oxygen, iron can react to form extremely 
toxic reactive oxygen species (ROS), in the well-known Fenton reaction: 
 
Fe2+ + H2O2 → Fe3+ + OH + OH- 
Fe3+ + H2O2 → Fe2+ + OOH + H+ 
 
These radical species are subsequently able to damage cellular structures, e.g. 
nucleic acids and membranes, severely impairing cellular functions.3 Thus, under 
oxidative conditions, iron is both rarely available and extremely toxic. 
The development of high-affinity iron uptake systems and the precise regulation of 
the iron homeostasis is therefore an essential process to sustain cellular life. In 
particular, in order to cope with iron-limiting conditions, microbes have developed 
mechanisms for highly selective metal uptake.4 The secretion of low-molecular 
weight organic chelators called siderophores is one of the main iron-mobilizing 
strategies used by both environmental and pathogenic strains to support their life 
under strict iron-liming conditions.5 
1.1.2 Siderophore classification 
The production and secretion of siderophores is the most efficient and widespread 
iron-scavenging strategy used by microorganisms (bacteria and fungi) to mobilize 
iron from iron-depleted environments.6 Most siderophores display a molecular 
mass below 1 kDa, coordinate the ferric iron via six donor atoms as an octahedral 
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complex (in an ferric iron:siderophore ratio of 1:1) and have an extremely high 
affinity (Kf = 1022 - 1049 M-1).2 After secretion to the extracellular space and 
complexation of iron, the ferric iron-siderophore complex is subsequently 
selectively and actively imported into the intracellular space, the iron is released 
from the chelator-complex and channeled to the intracellular targets.3,7,8 Although 
they perform the same biological function, siderophores are structurally diverse 
natural products and display great chemical diversity, in both iron coordination and 
their biosynthesis.9 Siderophores may have a linear, exocyclic, endocyclic or tripodal 
structure.10 On the other hand, on the basis of the chemical nature of the moieties 
involved in ferric iron coordination, they are usually classified into three main 
classes: catecholates (better termed as “aryl caps”), hydroxamates, and (α-hydroxy)-
carboxylates. The most commonly known catecholate siderophores are the tris-
cathecolates enterobactin11 (Escherichia coli) and bacillibactin12 (Bacillus subtilis) 
which possess the highest known affinity constants for the siderophore:metal 
complex, with (Fe:enterobactin)3- being 1049 M-1 and (Fe:bacillibactin)3- being 1047 M-1, 
respectively. Tris-hydroxamate siderophores coelichelin13 [Streptomyces coelicolor 
A3(2)] and erythrochelin14 (Saccharopolyspora erythraea) contain iron-coordinating 
hydroxamic acid moieties, deriving from the subsequent tailoring of hydroxylated 
side chain amino groups of lysine or ornithine residues, via acetylation or 
formylation.15 Moreover, amphibactins16 and aquachelins17 are additional examples 
of tris-hydroxamate amphiphilic siderophores isolated from the marine 
environment. Finally, carboxylate-type siderophores generally utilize α-
hydroxycarboxylic acids as bidentate iron-chelating group. In the case of 
staphyloferrin A,18 two citrate groups provide the iron-coordinating moieties.  
However, the continuous discovery of new structures led to a more complex 
classification, due to the presence of at least two different coordinating groups 
within one molecule, resulting in “mixed-type” siderophores. A representative 
overview of the structural diversity of siderophores is shown in Figure 1.1. 
1.1.3 Siderophore assembly strategies 
In addition to the classification relying on the different iron-coordination functions, 
siderophores diversity can be further organized on the basis of their biosynthetic 
origin in NRPS-dependent (NRPS, non-ribosomal peptide synthetase) and NRPS-
independent.19,20 NRPS-dependent is the most prominent and extensively studied 
assembly strategy. Notable examples are the tris-catecholate enterobactin11 and the 
tris-hydroxamate coelichelin,13 whose genetic and biochemical analysis has allowed 
for the elucidation of alternatives strategies to the canonical linear NRPS assembly 
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logic (the detailed biosynthetic mechanism will be discussed in the sections 1.2.3.2 
and 1.2.3.3). 
 
Figure 1.1 Structures of representative siderophores. The classification is based on the 
functional groups involved in octahedral coordination of ferric iron: catecholate/phenolate, 
carboxylate and hydroxamate (and the corresponding mixed structures). The siderophores 
are: bacillibactin (Bacillus subtilis), yersiniabactin (Yersinia pestis), staphyloferrin A 
(Staphylococcus spp.), amphibactin D (Vibrio sp. R-10), fuscachelin A (Thermobifida fusca 
YX), petrobactin (Bacillus anthracis), aerobactin (Shigella flexneri 5 str. 8401) and 
mycobactin J (Mycobacterium tuberculosis). 
The second class of siderophores is synthesized following an NRPS-independent 
pathway. The first non-ribosomally independent siderophore (NIS) to be discovered 
was aerobactin, a mixed citrate-hydroxamate type siderophore isolated from 
different Gram-negative bacteria, including E. coli, Shigella, Yersinia and Salmonella 
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spp. The gene cluster responsible for the biosynthesis of aerobactin is composed of 
four genes (Figure 1.2).21 Analysis of the aerobactin gene cluster revealed iucD to 
encode an FAD-dependent monooxygenase that catalyzes ε-amino group 
hydroxylation of L-Lys to ε-N-L-hydroxylysine (L-hLys).22 This hydroxylated 
intermediate is further tailored to ε-N-L-acetyl-N-L-hydroxylysine (L-haLys) by the 
acetyltransferase IucB, under the consumption of acetyl-CoA.23 Then, in the 
postulated model for aerobactin biosynthesis, it is proposed that the synthetase 
IucA mediates the first acylation of the α-amino group of L-haLys with a prochiral 
carboxyl group of citric acid, subsequently followed by the second IucC-catalyzed 
acylation of the remaining citric acid carboxyl group with an additional L-haLys 
building block. The homology of IucA and IucC with other biochemically 
characterized NISs associated with the biosynthesis of desferrioxamines and 
putrebactin, further suggested these reactions to require nucleotide triphosphates 
(NTPs) as cosubstrates for the activation of carboxyl groups.24,25 Furthermore, as 
IucA and IucC constitute the prototypical examples of NISs, every NIS-dependent 
biosynthetic pathway involves at least one synthetase homologous to them.26 
 
 
Figure 1.2 The postulated pathway for aerobactin biosynthesis. The FAD-dependent 
monooxygenase IucD hydroxylates the ε-amino group of L-Lys, subsequently acetylated to L-
haLys by the IucB acetyltransferase. The tailored building block is condensed with a carboxyl 
group of citric acid by IucA. Analogously, IucC catalyzes the second condensation reaction to 
give rise siderophore aerobactin. In analogy with other NIS synthetases, it is proposed that 
the condensation reactions take require the consumption of NTPs for the activation of the 
citrate’s carboxylic functions. 
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1.2 The non-ribosomal assembly of peptides 
Non-ribosomal peptide synthetases (NRPSs) are large multimodular megaenzymes 
that catalyze the biosynthesis of biologically active peptides.27 In contrast to 
ribosomal peptide synthesis, the assembly of the oligopeptide is carried out in an 
mRNA-independent function.28 NRPS encoding genes are widely spread in nature, 
being mainly found in bacteria and fungi.29 The best examined producing species of 
NRPS-assembling natural products are soil actinobacteria, who have already proved 
to be a rich source of new potent and pharmacologically-relevant molecules.30,31  
 
Figure 1.3 The catalytic steps of an elongation NRPS module are shown: (1) Substrate 
recognition and activation by the A-domain under ATP-consumption, (2) Substrate transfer 
onto the 4'-phosphopantetheine (ppan) cofactor covalently attached to an invariant Ser of a 
PCP-domain, (3) trapping of the thioesterified amino-acid in the acceptor site of the C-
domain, followed by condensation with the incoming building block trapped in the donor-
site, (4) trapping of the peptidyl-S-ppan moiety in the donor-site of the downstream C-
domain. 
The genetic and biochemical characterization of the NRPS assembly machinery 
revealed a multimodular organization, which can be further dissected into single 
catalytic domains.32 Each module is responsible for the incorporation of a building 
block, catalyzing the elongation of the oligopeptide chain by one unit. In particular, 
a minimal module (Figure 1.3) contains all the essential units required for the 
recognition and activation of the monomer [adenylation (A)-domain], the formation 
of the peptide bond [condensation (C)-domain] and the translocation of the peptidyl 
intermediates to the subsequent module [peptidyl-carrier-protein (PCP)-domain]. A 
fourth catalytic NRPS domain, the thioesterase (TE)-domain is responsible for the 
release of the product from the NRPS machinery. Recently the crystal structure of 
SrfA-C, the termination module of the surfactin synthetase, was determined, 
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granting insights into unique inter-domains communication (Figure 1.4).33 The C-
domain and the core of the A-domain constitute a catalytic platform on which the 
PCP-domain and the smaller C-terminal Asub-domain are located. The terminal TE-
domain is in close contact with the upstream PCP-domain, via a short linker region. 
 
Figure 1.4 The crystal structure of the termination module (C-A-PCP-TE) of the surfactin 
NRPS SrfA-C (PDB code: 2VSQ). The C-domain (grey) and the Acore-domain (red) constitute 
the work bench on which the PCP-domain (green) and the smaller C-terminal Asub-domain 
(dark red) are located. The terminal TE-domain (orange) is in close contact with the upstream 
PCP-domain. The inter-domain linker regions are highlighted in blue. The light-cyan C-
terminal helix is the peptidic fusion-tag for protein purification. 
1.2.1 The essential NRPS domains 
1.2.1.1 The adenylation domain 
The adenylation (A)-domain is responsible for the recognition and activation of the 
substrate.27 Each A-domain usually consists of ~550 amino acids and comprises a 
larger N-terminal core (Acore, ~450 amino acids) and a smaller C-terminal 
subdomain (Asub, ~100 amino acids). This domain organization is shared along the 
three known A-domain structures (PheA, DhbE and DtlA) and is also extended to 
other adenylate-generating enzymes, like the acetyl-CoA synthase ACS from 
Salmonella enterica and the firefly luciferase from Photinus pyralis.34-38 
Prior catalyzing the activation reaction, the A-domain is responsible for substrate 
recognition. The analysis of the crystal structure of the dissected A-domain from the 
gramicidin S synthetase PheA gave insights into the relative position of the amino 
acid substrate within the binding pocket.34 This allowed the definition of an A-
domain specificity-conferring code (given by the ten amino acids surrounding the 
substrate binding pocket), and enabled the development of bioinformatic prediction 
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tools which facilitated the identification and the isolation of NRPS-derived natural 
products via genome mining approaches.39-44 
After the recognition of the proper building block, in the presence of Mg2+ and ATP, 
the A-domain activates the amino acid substrate as an adenylate, with the 
subsequent release of pyrophosphate. Although this reaction is analogous to the one 
carried out by aminoacyl-tRNA synthetases during ribosomal protein synthesis, the 
enzymes do not share any sequential or structural homology. Furhtermore, A-
domains lack a proof-reading mechanism that, combined with relaxed substrate 
specificity, often results in the synthesis of NRPs with different amino acid 
composition by one synthetase.45 
1.2.1.2 The peptidyl-carrier-protein domain 
The peptidyl-carrier-protein (PCP)-domain, also known as thiolation (T)-domain, is 
responsible for the covalent tethering of the monomeric building blocks and the 
translocation of the peptidyl intermediates.46 It is usually located at the C-terminus 
of an A-domain and, despite its size of ~80 amino acids, it is of the greatest 
importance for the functionality of the NRPS assembly line. PCP-domains are post-
translationally modified at a highly-conserved Ser redidue embedded in the core-T 
motif (GGxS) with a 4'-phospopantetheine (ppan) cofactor. In fact, during non-
ribosomal peptide synthesis, the mobile ppan-arm delivers all the substrates and 
peptidyl intermediates as thioesters to the adjacent NRPS domains for the formation 
of the peptide bond, for modification of the PCP-bound substrate or for product 
release. 
The conversion from the inactive apo-PCP to the active holo-PCP is mediated by 
phosphopantetheinyl-transferases (PPTases, e.g. Sfp), which catalyze the 
nucleophilic attack of the hydroxyl-group of the conserved Ser residue onto the β-
phosphate of a donor coenzyme A molecule (and the subsequent release of 3',5'-
adenosinediphosphate).47,48  
PCPs share a high degree of sequential and structural homology with acyl-carrier-
proteins (ACP) of fatty acid (FAS) and polyketide synthases (PKS).49 NMR-based 
studies showed that the PCP-domain adopts a four-helix bundle structure and exists 
in three different conformational states: the apo (A), the holo (H) and the A/H form.50 
When the PCP is in the apo-state, both A and A/H coexist. On the other hand, when 
the PCP is in the holo-state, it slowly interconverts between the H and A/H states. 
These extensive conformational changes evidence the dynamic nature of the PCP 
carrying the ppan-bound substrates and intermediates to the adjacent domains. In 
particular, the terminal sulfhydryl-group of the ppan-arm is able to move 
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approximately 16 Å, confirming the long-proposed swinging mode of the ppan 
prostetic group during the non-ribosomal peptide synthesis. 
1.2.1.3 The condensation domain 
The condensation (C)-domain is the last essential domain of an NRPS module and 
carries out the peptide bond formation.51 The C-domain contains an acceptor and a 
donor site, which harbor the nucleophilic aminoacyl-S-PCP substrate and the 
electrophilic peptidyl-S-PCP electrophilic substrate, respectively.52,53 The formation 
of the peptide bond is initiated by the nucleophilic attack of the α-amino group of 
the aminoacyl-S-PCP substrate onto the thioester bond of the peptidyl-S-PCP. Upon 
the amid bond formation, the elongated peptide is transferred onto the downstream 
PCP-domain and serves as a donor substrate in the downstream condensation step. 
All C-domains have been found to operate unidirectionally, translocating the 
growing peptide chain towards the C-terminus.53,54 In addition, following to the 
prototypical co-linearity assembly rule of non-ribosomal peptides, the number of C-
domains is in agreement with the number of peptide bonds found in the mature 
NRP. 
C-domains contain approximately 450 amino acids and are composed of two big 
similar subdomains arranged in a V-shaped canyon-like structure, of which the N-
terminal one shares high sequence and structural homology with the 
chloramphenicol acetyltransferases.55-57 This characteristic V-shaped structure allows 
the correct positioning of the up- and downstream PCP-domains at each opening 
(acceptor and donor site), with respect to the highly conserved catalytic His residue 
of the HHxxxDG motif, which remains at the bottom of the canyon. Althought the 
exact reaction mechanism has not yet been elucidated, it is suggested that the 
second His residue takes part in the deprotonation of the α-amino group of the 
aminoacyl-S-PCP substrate, enhancing the electron-donor character of the 
nucleophilic PCP-bound substrate, and therefore facilitating the reaction. 
1.2.1.4 The thioesterase domain and the termination of non-ribosomal peptide 
assembly 
The thioesterase (TE)-domain is the fourth essential domain of NRPSs and is usually 
located in the termination module of the assembly line. TE-domains catalyze the 
product release from the NRPS, resulting in a linear, cyclic or branched cyclic 
peptide.58,59 These independently working domains contain approximately 230-270 
amino acids arranged in an α/β hydrolase fold, similarly to serine proteases and 
lipases.60-62 The catalytic Ser-His-Asp triad is located in a deep pocket, shielded from 
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solvent by an α-helical lid region, or by the peptide itself. The hydrolytic release of 
the template-bound NRP occurs in a two-step mechanism: first the formation of an 
acyl-O-intermediate with the active Ser, which is subsequently cleaved by the attack 
of a nucleophile.63 The different nature of the nucleophilic group results in the 
different topology of the molecule: if an intramolecular attack occurs, a cyclic (or a 
branched cyclic) molecule is released. On the other hand, if a water molecule cleaves 
the intermediate, a linear peptide is released.64-66 
The release of the peptide chain from the NRPS assembly machinery can also occur 
via different alternative strategies, for example via the reduction of the C-terminal 
carboxyl group to the corresponding aldehyde or alcohol, in an NAD(P)H 
dependent manner.67,68 This reaction is catalyzed by a C-terminal reductase (R)-
domain, which takes the place of the TE-domain. In addition, in several NRPSs, 
product release is carried out by a C-terminal C-domain, proposed to mediate the 
cyclorelease of the peptide. Furthermore, the existence of in trans acting TE-domains 
has been postulated for NRPSs that lack any C-terminal domain for the release of 
the NRP product.13,69 
1.2.2 Additional NRPS domains and related enzymes 
The structural and functional diversity of NRPS-derived natural products is usually 
extended by the addition of auxiliary domains to the essential core functions. in cis 
operating NRPS domains are responsible for the on-line modification of the peptidic 
backbone, whereas other stand-alone domains modify and tailor NRPS building 
blocks prior to the incorporation into the assembly line. Finally, a repair mechanism 
of the assembly machinery carries out in the regeneration of misprimed PCP-
domains. 
1.2.2.1 In cis operating modification enzymes 
1.2.2.1.1 The epimerization domain 
The presence of D-configured amino acids can be observed in numerous NRPS-
derived compounds.64,70 The incorporation of D-configured amino acids in the 
peptidic backbone is usually mediated by epimerization (E)-domains, located 
directly downstream of the adjacent PCPs, and represents one of the major 
differences between NRP and ribosomal peptide biosynthesis. E-domains epimerize 
L-configured amino acids immediately after their immobilization as aminoacyl-S-
PCP intermediates. The E-domains of initiation modules generate a mixture of PCP-
S-L/D-monomers, later correctly selected by the downstream C-domain prior to 
peptide bond formation. On the other hand, for E-domains embedded in elongation 
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modules, the epimerization occurs before the transfer to the subsequent module of 
the assembly line. Also in this case the downstream C-domains ensure the correct D-
configured substrate specificity.71,72  
1.2.2.1.2 The cyclization domain 
The heterocyclization of cysteine, serine or threonine side chains resulting in the 
corresponding five-membered thiazoline, oxazoline or methyloxazoline 
heterocycles is a structural feature found in several NRPs. These modifications 
increase the diversity of the natural product, rigidifing the peptide backbone and 
providing either metal-chelating or intercalating properties.73-76 The cyclization (Cy)-
domains are responsible of these structural modifications and are variants of C-
domains. First, Cy-domains catalyze the usual peptide bond formation and then 
carry out cyclization of the nucleophilic sidechain of cysteine or the hydroxyl 
sidechain of serine or threonine onto the newly formed peptide bond. The newly 
formed heterocycles are often associated with oxidation (Ox)-domains, that catalyze 
the FMN-dependent two-electron oxidation of the thiazoline or oxazoline ring 
structures to the thermodynamically more stable corresponding thiazoles or 
oxazoles.73,77 Conversely, the reduction of thiazoline or oxazolines structures is 
mediated by in trans operating NAD(P)H-dependent reductases that recognize and 
directly reduce the PCP-bound substrate.78 
1.2.2.1.3 The methylation domain  
Methylation (MT)-domains catalyze the in cis transfer of a methyl group from a S-
adenosylmethionine (SAM) donor to a carbon, nitrogen or oxygen atom of the NRP 
chain. Therefore, on the basis of the different site of methylation, MT-domains are 
classified as C-MT, N-MT or O-MT, respectively.79 MT-domains share a bidomain 
structure, with the first subdomain containing the binding site for methyl group 
donor, while the second subdomain harbors the pocket for the acceptor substrate. In 
contrast to the domains described so far, MT-domains are usually embedded within 
the corresponding A-domains, between the core A8- and A9-motifs, separating the 
Acore, and Asub,subunits.  
1.2.2.1.4 The formylation domain 
The N-formylation of the N-terminal α-amino group of a non-ribosomal peptide 
chain is catalyzed by the formylation (F)-domain, through the transfer of a formyl 
group from the N10-fH4F or N5-fH4F donor cosubstrate to the α-amino function of the 
activated aminoacyl-S-PCP substrate. The linear gramicidin NRPS LgrA contains a 
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F-domain in the initiation module, upstream of the corresponding A-domain 
(Figure 1.5).67 The F-domain catalyzes the reaction on the PCP-bound amino acid (L-
Val) and its N-formylation is essential for the subsequent elongation of the 
peptide.80 
 
Figure 1.5 The F-domain of the linear gramicidin NRPS LgrA is located at the N-terminus of 
the initiation module. Upon activation of the L-Val substrate, the F-domain catalyzes the 
transfer of a formyl moiety from the N10-fH4F or N
5-fH4F cosubstrate to the α-amino function 
of the activated L-Val-S-PCP. This reaction is required for the subsequent elongation step. In 
the picture, the dissected NRPS LgrA lacks the terminal E-domain. 
1.2.2.2 Modifications through in trans acting tailoring enzymes 
1.2.2.2.1 Methylation 
Similar to in cis acting methyltransferases, stand-alone methyltransferases catalyze 
the in trans SAM-dependent (or N5-methylH4F-dependent) methylation of carbon, 
nitrogen, oxygen or sulphur atoms of building blocks, prior to their incorporation 
by the NRPS assembly line.81 Interestingly, these enzymes generate the methylated 
amino acid by a two-step mechanism, by first methylating the corresponding α-
ketoacid, followed by the transamination of the corresponding α-keto group, 
resulting in the correct building block (Figure 1.6).82-84 
 
Figure 1.6 Side chain C-methylated amino acids are generated in a two-step reaction via the 
SAM-dependent modification of the corresponding α-ketoacid, followed by the 
transamination of the corresponding α-keto group. (A) GlmT, from the CDA-biosynthetic 
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gene cluster [S. coelicolor A3(2), A], catalyzes the stereospecific methylation of α-KG to (3R)-
3-methyl-2-oxoglutarate followed by the subsequent conversion to 3-methyl-L-glutamate.82,83 
(B) MppJ (mannopeptimycin gene cluster, Streptomyces hygroscopicus) catalyzes the 
analogous reaction on phenylpyruvate but is not stereospecific.84,85 The NRPS machinery 
solely incorporates the (2S,3S)-3-methyl-phenylalanine precursor, found in 
mannopeptimycin.  
1.2.2.2.2 Hydroxylation 
Three different classes of enzymes catalyze hydroxylation reactions: FAD-
dependent monooxygenases, non-heme Fe(II)/α-KG-dependent oxygenases and 
heme Fe(II)-oxygenases, the former two will be discussed (Figure 1.7). FAD-
dependent monooxygenases catalyzes a broad variety of oxygenation reactions 
(including epoxidations) and are often involved in the biosynthesis of iron-
coordinating hydroxamate-groups of both NRPS-dependent and NRPS-
independent siderophores.15,86,87  
 
Figure 1.7 Examples for the hydroxylation of free building blocks or PCP-bound substrates. 
(A) The FAD-dependent monooxygenases CchB and IucD mediate the δ-N-hydroxylation of L-
Orn during the assembly of the siderophores coelichelin and aerobactin.22,88 (B) The non-
heme Fe(II)/α-KG-dependent oxygenases AsnO and VioC are responsible for the hydroxylation 
of free L-Asp and L-Arg substrates.89,90 (C) During kutzeneride biosynthesis the two different 
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non-heme Fe(II)/α-KG-dependent oxygenases KtzO and KtzP hydroxylate PCP-bound L-Glu 
generating the corresponding threo or erythro products, respectively.91 
These enzymes require the reduction of the FAD-cofactor, with the needed electrons 
usually supplied by an NAD(P)H cosubstrate. Fe(II)/α-KG-dependent oxygenases 
couple the oxidative conversion of the substrate with the decarboxylation of the 
cosubstrate α-ketoglutarate to succinate and carbon dioxide. Both enzyme classes 
acts as in trans hydroxylating catalysts, prior to the incorporation of the modified 
building block by the NRPS machinery.89,90,92,93 In addition, Fe(II)/α-KG-dependent 
oxygenases can either hydroxylate free or PCP-bound substrates.91 
1.2.2.2.3 Acetylation and formylation 
Acetylation and formylation reactions are often found as consecutive steps of the 
hydroxylation of the amino group of the side chain of lysine and ornithine moieties, 
giving rise to flexible iron-coordinating hydroxamate functionalities.15 Very recently, 
the Mcd enzyme from the erythrochelin gene cluster has been characterized, 
demonstrating the transfer of an acetyl group from an acetyl- or malonyl-CoA 
donor to the side chain of an L-hOrn amino acid, establishing a pathway for the 
biosynthesis of the L-haOrn amino acid (Figure 1.8).94 A similar study aimed at the 
characterization of the putative formyltransferase CchA, proposed to be involved in 
the formylation of L-hOrn in the coelichelin biosynthesis gene cluster, was not able 
to successfully confirm its function. Nevertheless, an analogous “hydroxylation 
first” model for the biosynthesis of the nonproteinogenic amino acid L-fhOrn has 
been inferred, based on the substrate specificity of the ornithine monooxygenase 
CchB.88 
 
Figure 1.8 Coupled enzymatic biosynthesis of the L-haOrn building block.94 EtcB converts L-
Orn into L-hOrn and the hydroxylated intermediate serves as a substrate for the subsequent 
Mcd-dependent acetylation reaction, giving rise to the iron-coordinating L-haOrn. 
1.2.2.3 NRPS repair mechanism: the type II thioesterase 
Approximately 80% of CoA, the precursor of the ppan cofactor required during the 
priming of PCP-domains, is acetylated in bacteria; therefore, the incorporation 
within the NRPS assembly line of these misprimed ppan cofactors interrupts the 
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NRP biosynthesis. Consequently, in order to overcome this critical step, a second 
type of thioesterase (TEII) is often found in NRP gene clusters that ensures the 
deacylation of the misprimed PCP-domain.95-97 These stand-alone domains display 
structural homology with canonical NRPS termination domains, but the overall 
greater accessibility of the catalytic pocket ensures the promiscuity of the TEII 
enzymes towards a broad range of short chain acyl-misprimed PCP-domain 
substrates.98 For the same reason, TEIIs are not able to release peptidyl-S-PCP bound 
substrates. 
1.2.3 Classification of non-ribosomal assembly line logic 
1.2.3.1 Linear NRPS-assembly line logic 
The prototypical and most extensively characterized NRPSs assemble the 
oligopeptide chain through a linear mechanism (type A). The classical modular 
organization (C-A-PCP) directly correlates, in both order and number of the 
building blocks, with the primary sequence of the assembled peptide. The release of 
the product is commonly mediated by a typical TE-domain located at the C-
terminus of the last elongation module, that cleaves the peptide from the NRPS 
through hydrolysis or macrocyclization. Typical examples derived from type A 
NRPS assembly lines are surfactin, tyrocidine, daptomycin and the ACV precursor 
of the β-lactam antibiotics (penicillins and cephalosporins, Figure 1.9).99-102  
 
Figure 1.9 AcvA is a prototypical NRPS responsible for the assembly of the ACV tripeptide, 
the precursor of the β-lactam antibiotics (penicillins and cephalosporins). 
1.2.3.2 Iterative NRPS-assembly line logic 
The iteratively operating NRPS assembly lines (type B) repeatedly use the 
enzymatic template during the biosynthesis of the natural product. The modular 
domain organization resembles type A NRPSs, but, in this case, an iteratively 
working termination module is responsible for the covalent connection of the 
constitutive repetitive units and subsequent product release. Examples of iteratively 
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assembled NRPs are the macrocyclic decapeptide gramicidin and the trilactone 
siderophores enterobactin and bacillibactin.12,67,103 In particular, enterobactin is a 
cyclic trimer composed of 2,3-DHB-L-Ser subunits, connected via three ester bonds 
between the side chain hydroxyl group of Ser and the carboxylic group of a second 
monomer (Figure 1.10). Coupled MS-analysis of the site-directed mutagenesis of the 
terminal TE-domain active site triad of the EntF NRPS allowed the postulation of an 
enterobactin biosynthetic model.104 The monomeric 2,3-DHB-L-Ser unit bound to its 
cognate PCP-domain is subsequently transferred onto the active-site Ser of the 
terminal TE-domain. The monomer remains TE-bound until a second monomer is 
presented on the adjacent PCP. TE-mediated ligation affords the TE-bound dimer 
and a third ligation reaction gives rise to the TE-bound trimer, which is finally 
cyclized and released from the enzymatic machinery. 
 
Figure 1.10 The postulated assembly mechanism of the siderophore enterobactin. The stand-
alone AMP-ligase EntE activates 2,3-DHB, which is subsequently transferred to the synthetase 
EntF by the ArCP-domain of EntB. Assembly of the trilactone enterobactin is realized by 
iterative dimerization and trimerization of the 2,3-DHB-L-Ser units (coloured in black, red 
and blue).  
1.2.3.3 Non-linear NRPS assembly line logic 
In non-linear NRPSs (type C), the assembly of the peptide does not follow the 
typical linear elongation logic of the modular type A and type B synthetases. In fact, 
the number and organization of modules and/or domains does not reflect the 
primary sequence of the assembled product. In addition, lone standing individual 
domains are often involved in product assembly. Thus, in Type C NRPSs, the 
natural product structure prediction on the basis of the modular NRPS organization 
is often impeded or not correct. Notable examples of non-linear NRPS derived 
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natural products are the antibiotic congocidin (Streptomyces ambofaciens) and the tris-
hydroxamate siderophore coelichelin.13,105 In this latter case, a trimodular NRPS is 
responsible of the assembly of a tetrapeptide and the suggestion of the so-called 
“module skipping” mechanism allowed the postulation of a biosynthetic model 
(Figure 1.11).13,106 Before the final release, with the corresponding tripeptide bound 
to the terminal PCP-domain, the initiation module of the CchH NRPS activates a 
second L-fhOrn building block that is subsequently incorporated into the peptide 
chain, to give rise to the final tetrapetide. 
 
Figure 1.11 Coelichelin assembly is catalyzed by the trimodular NRPS CchH and follows a 
non-linear logic, due to the presence of four amino acids within the synthesized 
siderophore.13 The biosynthesis of coelichelin is initiated by the FAD-dependent 
monooxygenase CchB that catalyzes the hydroxylation of L-Orn to L-hOrn,88 which is either 
directly incorporated into the oligopeptide by the third module of the NRPS CchJ or further 
tailored resulting in L-δ-N-formyl-δ-N-hydroxyornithine (L-fhOrn) by the formyltransferase 
CchA (not shown).107 The initiation of coelichelin assembly requires is the activation and the 
covalent tethering of L-fhOrn to the first module of CchH. The reaction proceeds with the 
condensation of Thr and the subsequent isopeptide linkage with L-hOrn, following (until this 
point) a linear NRPS assembly logic. Prior to hydrolytically release of the tetrapeptide, it is 
suggested that the first CchJ module additionally activates and tethers a second L-fhOrn 
building block, which is incorporated into the peptide by nucleophilic attack of the α-amino 
group of hOrn. The non-consecutive reuse of a NRPS module within the assembly of a single 
NRP molecule has therefore been termed “module skipping” mechanism.  
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1.3 Rational strategies for natural product discovery via genome mining 
The discovery of natural products often relies on bioassay-guided fractionation of 
extracts from different natural sources and the subsequent isolation of the bioactive 
compound. This employed strategy has historically led to the discovery of many 
bioactive compounds, used in clinical therapy as antifungal, anticancer and 
immunosuppressive agents.30 Lately, the discovery that the systematic cultivation of 
one species under several conditions strongly influences secondary metabolite 
production (OSMAC, One Strain - MAny Compounds approach) allowed the 
discovery of different natural products.108 In recent years, with the increasing 
amount of information derived by huge advances in sequencing technologies, a 
plethora of sequenced microbial genomes has revealed a multitude of gene clusters 
associated with the biosynthesis of secondary metabolites.109,110 This quantity of 
information, in combination with a substantial increase in the understanding of 
natural product biosynthesis has paved the way for the mining of genomes for 
bioactive compounds.32 
Since many microbial natural products are assembled by multimodular synthases 
and synthetases (e.g. polyketides and non-ribosomal peptides), the development of 
bioinformatic tools for the analysis and the prediction of the modular organization 
and the substrate specificity of these assembly machineries has formed the basis for 
the subsequent development of genome mining approaches, allowing the isolation 
of new natural products solely on the basis of the genome sequence of the target 
organism.32,40,111 The first microbial organism to be extensively analyzed for the 
production of unknown secondary metabolites was S. coelicolor A3(2). Within its 
genome, several gene clusters were identified to encode for new biosynthetic 
pathways, later associated to newly isolated natural products. Besides, the gene 
clusters that still remain “orphan” with respect to their cognate metabolites, were 
renamed “cryptic”.13,112-115 
During the past years, several approaches for microbial genome mining have been 
developed, leading to a successful characterization of new natural products (Figure 
1.12). The first approach solely relies on the prediction of the physico-chemical 
properties of the target compound, and has led to the identification of salinilactam 
A (Salinispora tropica).116 The sequence analysis of a modular PKS gene cluster 
putatively encoding a lysine-primed polyene macrolactam allowed the isolation and 
the structural characterization of salinilactam A solely on the basis of polyene UV-
absorption properties. An alternative approach is represented by the in vitro 
reconstitution of natural product biosynthesis. This strategy uncouples the 
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biosynthetic enzymes from their native regulatory mechanism, through their 
recombinant production in a heterologous host. The two-component lantibiotic 
haloduracin (Bacillus halodurans C-125) has been isolated by the incubation of the 
biosynthetic enzymes with the ribosomally synthesized substrates in vitro.117 
 
Figure 1.12 Genome mining strategies applied for the isolation of new natural products. (A) 
The isolation of salinilactam A (S. tropica) relied on the prediction of the physico-chemical 
properties of the cryptic natural product. (B) The inactivation of the natural product 
biosynthetic pathway, followed by the comparative metabolomic profiling, allowed the 
characterization of the siderophore coelichelin and its gene cluster [S. coelicolor A3(2)]. (C) 
A genomisotopic approach was employed for the identification of the lipopeptide orfamide A. 
On the basis of the bioinformatic analysis of the A-domain substrate specificities, 15N-Leu was 
fed into the cultures of Pseudomonas fluorescens Pf-5; the subsequent 1H-15N-NMR 
experiments led to the identification and the isolation of the natural product.  
The inactivation of gene cluster-associated genes and subsequent comparative 
metabolomic profiling of the wild-type and mutant strains has been successfully 
applied for the discovery of the hydroxamate-type siderophore coelichelin.13 The 
main drawback of this strategy, which does not require the structure prediction of 
the secondary metabolite, is the genetic accessibility of the target strain. 
Additionally, the change in the metabolite profile of the wild-type and the mutant 
strain has to be detectable. Comparative metabolic profiling can also be applied to 
strategies that require the heterologous expression of cryptic biosynthetic gene 
cluster into a genetically transformed non-producing host strain. In this case, the 
profile comparison of the transformed strain with a control counter-part allows the 
natural product identification.118-120 
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The last more general strategy described for natural product discovery is the 
genomisotopic approach, which has been successfully applied for the 
characterization of the NRPS-derived cyclolipopeptide orfamide A (Pseudomonas 
fluorescens Pf-5).121 This technique combines the bioinformatic predictions of the 
modular assembly machinery with the incorporation of a stable-isotope precursor 
added to the growing culture, allowing the labeling, detection and structural 
characterization of the assembled product. In the case of orfamide A, 15N-labeled L-
Leu was fed to cultures of P. fluorescens Pf-5 and HPLC fractions of the culture 
extracts were analyzed via 1H-15N-NMR experiments for the successful 
identification of isotope-labeled metabolites. 
In conclusion, the choice of the best strategy for the successful characterization of 
new natural products via genome mining must take several aspects into account, 
among them, the culturing conditions and the genetic accessibility of the producing 
strain and the availability of the proper instrumentation for the isolation and 
structural characterization of the natural product. 
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1.4 Aim of the work 
Rhodococcus spp. are extensively studied as extraordinary biocatalysts for steroid 
production and fossil fuel biodesulfurization and as tools suitable for 
bioremediation purposes.122,123 This widespread biotechnological and industrial 
interest derive from their diverse metabolic capabilities. Furthermore, genome 
sequencing information revealed Rhodococcus spp. to possess a vast genetic potential 
for secondary metabolite production.124 However, only very few natural products 
have been isolated from this genus, among them two siderophores, heterobactin A 
and rhodobactin, isolated from Rhodococcus erythropolis IGTS8 and Rhodococcus 
rhodochrous OFS, respectively (Figure 1.13).125,126 They belong to the hydroxamate-
catecholate mixed type family, with the common presence of 2,3-dihydroxybenzoic 
acid (2,3-DHB) and differently modified ornithine residues within their structures. 
In both cases, no gene clusters responsible for siderophore biosynthesis have been 
identified. 
 
Figure 1.13 Chemical structures of representative siderophores isolated from Rhodococcus 
strains: heterobactin A and rhodobactin were isolated from R. erythropolis IGT8 and R. 
rhodochrous OFS, respectively. 
Rhodococcus jostii RHA1 was isolated from a lindane-contaminated soil and is 
known for its ability to transform polychlorinated biphenyls and to utilize a wide 
range of aromatic compounds, carbohydrates, nitriles, and steroids as its sole 
energy source:127 these features make it a species of significant industrial interest. In 
this context, its genome sequence has been published in 2006 and contains 
approximately 9.7 Mbp arranged in one linear chromosome and three additional 
linear plasmids. R. jostii RHA1 also contains more that 30 NRPS and PKS genes, 6 of 
which exceed 25 kbp, providing evidence of an extensive and uncharacterized 
secondary metabolism.124 
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On the basis of this knowledge, the isolation and the structural characterization of 
the endogenous siderophore of R. jostii RHA1 will confirm the metabolic capacity of 
the strain to produce secondary metabolites. Furthermore, the genome mining 
identification of the gene cluster responsible for the biosynthesis of the molecule 
will permit the rational construction of isogenic deletion mutant strains. 
Subsequently, the metabolic profile comparison between the wild-type and the 
mutant strains will undoubtedly connect the biosynthesis of the natural product 
with the corresponding genes. Finally, the biochemical characterization of the 
recombinantly-produced enzymes associated with the biosynthesis of the 
siderophore will integrate the genetic results and will allow the postulation of a 
model for the biosynthesis of the newly-discovered iron-scavenging compound.
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2.1 Equipment 
Table 2.1 List of the devices used in this study. 
device manufacturer and type 
Autoclave Tuttnauer 5075 ELV, Fedegari Autoclavi SPA FVA3/A1 
Centrifuges Sorvall RC 5B Plus and RC6+ (SS‐34, SLC‐300, SLC‐4000 rotors), 
Heraeus Minifugue RF and Megafugue 1.0R, Eppendorf 5415 D, 5415 R 
and 5702 R 
Clean bench Antair BSK 
Documentation system 
for DNA‐electrophoresis 
gels 
Cybertech CS1 camera, Mitsubishi video copy thermo printer 
Electrophoresis chamber Agarose gel chambers manufactured in‐house (PUMa, Marburg), Bio‐
Rad Mini‐PROTEAN 3 gel chamber 
Electroporation Bio-Rad Gene-Pulser II 
Fast protein liquid 
chromatography (FPLC) 
system 
Amersham Pharmacia Biotech Äktaprime and Äktapurifier: (pH/C-900, 
UV-900, P-900 and Frac-900 modules) 
French-press SLM Aminco French-Pressure Cell Press 5.1, Thermo Spectronic 
Standard Cell 40 KP 
HPLC-systems Agilent series 1100 (HPLC‐system with DAD‐ and ESI‐Quad‐MS‐ 
detection, vacuum degasser, quarternary pump, auto sampler, 
preparative fraction collector, column thermostat, HP‐ChemStation 
software) 
Thermo Scientific LTQ‐FT 
Applied Biosystems API QStar Pulsar i 
Incubators New Brunswick Scientific Series 25, Innova 4300 Shaker, Infors HT 
Multitron II and Unitron 
Lyophilizer Christ Alpha 2‐4 LSC 
NMR-spectrometer Bruker AV600 
pH meter Schott CG 840 
Pipettes Eppendorf Research series 
Rotary Evaporator Heidolph Laborota 4000 
Scintillation counter Packard Tri-Carb 2100-TR 
Spectrophotometer PEQLab Nanodrop ND‐1000; Pharmacia Ultrospec 3000 
Speed‐Vac Uniequip Univapo 150H 
Thermal cycler Eppendorf Mastercycler Personal 
Thermomixer Eppendorf Thermomixer comfort 
Vortexer Scientific Industries VortexGenie2 
Water deionizer Seral Seralpur Pro90CN 
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2.2 Chemicals, enzymes and consumables 
All chemicals not listed in Table 2.2 were purchased from Sigma-Aldrich 
(Steinheim, Germany), Fluka (Steinheim, Germany) or Merck (Darmstadt, 
Germany) in p.a. quality and were used without further purification. 
Table 2.2 Chemicals, enzymes and general materials and consumables. 
manufacturer product 
Applichem (Darmstadt, Germany) ampicillin, kanamycin, media components 
Biomol (Ilvesheim, Germany) DTT 
Brand (Wertheim, Germany) Plastbrand PS cuvettes 
Eppendorf (Hamburg, Germany) 1.5 and 2.0 mL reaction tubes 
Eurogentech (Seraing, Belgium) agarose, electroporation cuvettes 
GE Healthcare (Freiburg, Germany) IPTG, FPLC Ni-NTA and Superdex 200 5/150 GL SEC 
columns, yeast extract, aldolase, ovalbumin, ribonuclease, 
aprotinin protein standards 
Invitrogen (Karlsruhe, Germany) E. coli strains (BL21, TOP10) 
Macherey & Nagel (Düren, 
Germany) 
C8- and C18-HPLC columns (Nucleosil, Nucleodur) 
Merck4Biosciences - Novagen 
(Nottingham, UK) 
pET28a(+) 
Millipore (Schwalbach, Germany) Dialysis membranes (pore size: 0.025 μM), Amicon Ultra‐15 
concentrators 
MP Biomedicals (Illkirch, France) coenzyme A trilithium salt 
New England Biolabs (Frankfurt, 
Germany) 
desoxyribonucleotides (dATP, dTTP, dGTP, dCTP), DNA 
ladders, protein size markers, restriction endonucleases, 
Phusion Hi-Fidelity DNA polymerase, T4 DNA ligase 
Oxoid (Cambridge, UK) agar nr. 1, tryptone 
Perkin Elmer (Waltham, USA) Na4
32P2O7 
Phenomenex (Torrance, USA) Synergi Fusion RP‐80 HPLC column 
QIAgen (Hilden, Germany) QIAquick Gel Extraction kit, Ni‐NTA IMAC resin 
Roth (Karlsruhe, Germany) acrylamide solution, β‐mercaptoethanol, ethidium 
bromide, scintillation fluid 
Sarstedt (Nümbrecht, Germany) Pipette tips, Falcon tubes (15 and 50 mL) 
Schleicher & Schüll (Dassel, 
Germany) 
Sterile filters (0.20 and 0.45 μm), Whatmann-3MM paper 
Serva (Heidelberg, Germany) bromophenol blue, Triton X‐100 
Thermo Scientific (Waltham, USA) Hypercarb HPLC column 
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2.3 Oligonucleotides 
All oligonucleotides listed in Table 2.3 were purchased from Sigma-Aldrich 
(Steinheim, Germany) in desalted quality grade and were used for PCR 
amplification of the targeted genes. 
Table 2.3 List of oligonucleotides used in this work. Restriction sites inserted for cloning are 
underlined. 
primer name sequence (5'-3') restriction 
site  
plasmid target 
gene 
2319P1 CCCAAGCTTCGACTCGATGTCGAGGACGTGCA
G 
HindIII pK18mobsacB rhcB 
2319P2 CGGACGTTTTCATCGATCTCCCTGTTCTGTCG
AAAGGGACATCTAACAGGCACTCCTG 
  rhcB 
2319P3 CAGGAGTGCCTGTTAGATGTCCCTTTCGACAG
AACAGGGAGATCGATGAAAACGTCCG 
  rhcB 
2319P4 GCTCTAGACTGGTCGGGTTCTGCGCCATGATG XbaI pK18mobsacB rhcB 
2319A1F GCCGCTTCCATATGCCGGACAACATCGTCTCC
GCCTTC 
NdeI  rhcB 
2319A1R CATAGCTCGAGTCAGGTCCGCGGTGTGTCGCC
G 
XhoI  rhcB 
4793P1 GCATACAAGCTTCAGGAGGTCGTCAGATGATG
TTTCGCAG 
HindIII pK18mobsacB dhbE 
4793P2 GACTTTCGATGAGCACGAGCGTTCGCGTGACT
TCGTAACCCGACCCCGCTATC 
  dhbE 
4793P3 GATAGCGGGGTCGGGTTACGAAGTCACGCGAA
CGCTCGTGCTCATCGAAAGTC 
  dhbE 
4793P4 GCATTCTCTAGAGCCACACTGCACAAGGTGGT
ACTCG 
XbaI pK18mobsacB dhbE 
4793INT1 CTCGCCGAGATACGGATCGGGC   dhbE 
4793INT2 GTGGTGCAACTGCCGAACATCGTCG   dhbE 
4716P1 GCATACAAGCTTCTTCTTCGACCTCGGCGGCA
ACTCC 
HindIII pK18mobsacB rmo 
4716P2 GGATTGGTGCTCATCTCGCCTCGCTTGTCGAT
TCACTCATAGCTCGTTGTCCGTCC 
  rmo 
4716P3 GGACGGACAACGAGCTATGAGTGAATCGACAA
GCGAGGCGAGATGAGCACCAATCC 
  rmo 
4716P4 GCCTTCTCTAGACTCCATCGTGCTGTCCGCAT
ACCG 
XbaI pK18mobsacB rmo 
4716INT1 CGATTCGGGTGGCATCCCGGGATG   rmo 
4716INT2 CAGGAGCGACGACGTGATTCCGTG   rmo 
4712P1 CCGGAATTCGATCGCGTCCGCCGCTGTGATCG EcoRI pK18mobsacB rft 
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4712P2 GTCCAGGAGGACCGCGTTGAGAGTCTGACGGT
CCCGCGCCGACACCAT 
  rft 
4712P3 ATGGTGTCGGCGCGGGACCGTCAGACTCTCAA
CGCGGTCCTCCTGGAC 
  rft 
4712P4 GCTCTAGACGTCCCGGAAATGCACGACCAGCG XbaI pK18mobsacB rft 
4712INT1 CGATGACCATTCCGTCGCCTTCGTG   rft 
4712INT2 GACCATGAGGTCGTCCTCGCGATC   rft 
KANF ATGGATTGCACGCAGGTTCTC   kanR 
KANR CGATAGAAGGCGATGCGCT   kanR 
4793F GGGAATTCCATATGAGCACGAGCGTTCGCGCT NdeI pET28a(+) dhbE 
4793R CCCCAAGCTTTTACGAAGTCACGAACGTCTTC
TCC 
HindIII pET28a(+) dhbE 
4712F GGAATTCCATATGAGAGTCGCCACACTCGGAT
ATC 
NdeI pET28a(+) rft 
4712R ATAAGAATGCGGCCGCTCAGCTGAGGTAGCCG
CCG 
NotI pET28a(+) rft 
4716F GGAATTCCATATGAGTGAATCGCCGGAAACGG
TCG 
NdeI pET28a(+) rmo 
4716R ATAAGAATGCGGCCGCTCATCTCGCCTCGCTT
GTCGCATAC 
NotI pET28a(+) rmo 
2322F AAAAAACCATGGCTAGTTCCGCTTCCAGCACA
GTTCC 
NcoI pET28a(+) rhcE 
2322R AAAAAAAAGCTTGCGTGCTGCCGTCACCTCGA
A 
HindIII pET28a(+) rhcE 
CchApCB128 AAAAAAGAATTCATGCGGGTCGTCATGTTCGG
CT 
EcoRI pCB28a(+) cchA 
CchApCB128 AAAAAACTCGAGTCAGGGGCGGGCGGTCAG XhoI pCB28a(+) cchA 
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2.4 Plasmids 
2.4.1 pET28a(+) and pCB28a(+) 
The pET28a(+) expression vector system was employed for the production of 
recombinant proteins in E. coli (Figure 2.1). The vector adds a hexahistidine (6xHis) 
fusion tag at the N- or C-termini of the recombinant protein, to allow subsequent 
Ni-NTA affinity chromatography purification. Transcription of the cloned genes is 
dependent on both T7 RNA polymerase activity and dissociation of the LacI 
repressor from its corresponding operator, upon IPTG induction. Plasmid selection 
and maintenance is permitted by the kanR gene, which confers resistance to 
kanamycin. 
The pCB28a(+) expression vector is a derivative of pET28a(+) with an alternative 
multiple cloning site (MCS). 
 
Figure 2.1 (A) Physical map of pET28a(+). (B) Physical map of pCB28a(+). 
2.4.2 pK18mobsacB 
The pK18mobsacB plasmid is a mobilizing cloning vector for the conjugative 
transfer of DNA into a recipient host.129 Deriving from the E. coli pK18 plasmid,130 it 
features the lacZα fragment inserted within the MCS and the kanR gene for selection 
and maintenance (Figure 2.2). The mobilizing machinery of the RP4 plasmid131 
confers broad host-specificity between different Gram-negative and Gram-positive 
species.132-134 The sacB gene encodes for the B. subtilis levansucrase, which renders 
the recipient strain sensitive to sucrose, and thus is applicable as a negative-
selection marker.135-137 The plasmid was kindly provided by Dr. Robert van der 
Geize, University of Groningen, The Netherlands. 
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Figure 2.2 Physical map of pK18mobsacB. 
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2.5 Bacterial strains 
2.5.1 Rhodococcus jostii RHA1 
R. jostii RHA1 is a strain originally isolated from an insecticide-polluted soil sample. 
It is classified as a Gram-positive, non-sporulating and non-motile microorganism 
belonging to the Actinomicetales order.127 Its completely sequenced genome 
comprises one linear chromosome and three linear plasmids, covering 
approximately 9.2 Mbp in total.124 The strain has been cultured for the isolation of 
the siderophore rhodochelin, for the isolation of genomic DNA and for the 
construction of isogenic deletion mutants. The strain was kindly provided by Prof. 
Linday E. Eltis of the University of British Columbia, Vancouver, Canada. 
2.5.2 Escherichia coli TOP10  
The E. coli TOP10 strain was used as a natural host for cloning and plasmid 
propagation procedures. The genotype is: F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-leu)7697 galU galK rpsL (StrR) endA1 
nupG. 
2.5.3 Escherichia coli BL21 (DE3) 
The E. coli BL21 (DE3) strain was used as a general host for the heterologous 
expression of recombinant proteins using T7-promoter driven expression plasmids. 
It derives from the E. coli B strain and its genotype is: F– ompT hsdSB(rB–, mB–) gal dcm 
λ(DE3). The strain lacks the proteases Ion and OmpT to increase the half-life of the 
overproduced recombinant protein. In addition, the insertion of the λ prophage DE3 
carrying the IPTG-inducible T7 RNA polymerase (under the control of the lacUV5 
promoter) is essential for recombinant protein expression.138 
2.5.4 Escherichia coli S17-1 
The E. coli S17-1 strain (genotype recA pro hsdR RP4-2-Tc::Mu-Km::Tn7) was used 
as mobilizing strain for the transfer of the pK18mobsacB plasmid into the recipient 
R. jostii RHA1, through bacterial conjugation. The mobilizing elements of the RP4 
plasmid are stably integrated within the chromosome, in order to avoid self-transfer 
of the original conjugating vector.139. The strain was kindly provided by Dr. Robert 
van der Geize, University of Groningen, The Netherlands. 
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2.6 Culture media 
All media listed below were used for the cultivation and fermentation of the 
bacterial strains indicated above. If solid agar plates were required for the 
cultivation of the microorganism, agar nr. 1 was added to a final concentration of  
1.5 % (m/w). All media were sterilized by autoclavation, (121 °C, 1.5 bar, 20 min). 
Antibiotics and other additional temperature-labile components were added after 
sterile-filtration, prior to use. 
2.6.1 Lysogeny broth (LB-Miller) 
LB broth (buffered at pH 7) has been routinely used for the cultivation and the 
maintenance of R. jostii RHA1 and E. coli strains. 
component quantity (1 L) 
yeast extract 5 g 
tryptone 10 g 
NaCl 5 g 
 
For the selection of Rhodococcus transconjugants sucrose was added to a final 
concentration of 10% (m/w). Where required, antibiotics were added at the 
following concentrations: nalidixic acid 30 μg/mL, kanamycin 50 μg/mL for 
derivatives of pET28a(+), pCB28a(+) and pK18mobsacB integrants in Rhodococcus 
host, and kanamycin 25 μg/mL for derivatives of pK18mobsacB in E. coli. 
2.6.2 M9 minimal medium 
M9 minimal medium was used for the isolation and the fermentative production of 
rhodochelin.  
component quantity (1 L) 
Na2HPO4 · 2 H2O 8.5 g 
KH2PO4 10 g 
NH4Cl 1 g 
NaCl 0.5 g 
 
Prior to use, a concentrated trace element mix (100xMg/Ca/B1/Goodies) was 
prepared as follows and added to a final 1x concentration. Sterile glucose solution 
was used as a carbon source (final concentration: 4 g/L). Where required, Fe3+ was 
added from a sterile-filtered FeCl3 solution. 
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100x Mg/Ca/B1/Goodies 
component quantity (100 mL) 
MgSO4 1 M 20 mL 
CaCl2 1 M 1 mL 
thiamine 10 mM 1 mL 
Conc. goodies 25 mM 
ddH2O top up to volume 
 
Concentrated goodies  Stock salts solution140 
component quantity (100 mL)  component quantity (1 L) 
Stock salts sol. 50 mL  MgCl2 · 6 H2O 22.94 g 
MgSO4 · 7 H2O 3 g  CaCO3 2.0 g 
ddH2O top up to volume  ZnSO4 · 7 H2O 1.44 g 
   MnSO4 · H2O 0.85 g 
   CuSO4 · 5 H2O 0.25 g 
   CoCl2 · 6 H2O 0.24 g 
   H3BO3 0.06 g 
   HCl (conc.) 51.3 mL 
   ddH2O top up to volume 
 
 
  
Chapter 3 
Methods 
Methods 
 34 
3.1 Molecular biology techniques 
General molecular biology material and methods (e.g. DNA agarose-gel 
electrophoresis, protein SDS-PAGE, the composition of routine buffers solutions, 
etc.) are not described in this section and were carried out according to established 
protocols.141 
3.1.1 General strains maintenance 
All E. coli strains were routinely maintained on LB-agar plates and incubated at  
37 °C. R. jostii RHA1 and derivative strains were maintained on LB-agar plates at 
30 °C. Liquid cultures were incubated under continuous shaking at 180 rpm. 
Antibiotics were added where required. For long-term storage, sterile glycerol was 
added to a liquid culture [final concentration: 20% (v/v)] and the resulting stocks 
were stored at -80 °C.  
3.1.2 Preparation of genomic DNA 
For genomic DNA isolation, 5 mL of liquid culture were harvested by centrifugation 
and the resulting pellet was washed with 1 mL of water. The cell pellet was 
resuspended in 500 μL lysis buffer [100 mM TRIS, 50 mM EDTA, 1% (w/v) SDS, pH 
8] and acid-washed glass beads were added to a final volume of 1.25 mL. The 
mixture was vortexed for two minutes and the recovered supernatant was 
transferred into a new microfuge tube. 275 μL of 7 M ammonium acetate pH 7 was 
added and the solution was incubated for 5 min at 65 °C, and then for 5 min on ice. 
500 μL of chloroform were added and the mixture was vortexed for 2 min. 
Following a centrifugation step at 13,000 rpm for 5 min, the recovered aqueous 
phase was added to 800 μL of ice-cold isopropanol. The genomic DNA was 
precipitated by centrifugation (5 min, 13,000 rpm), prior to 5 min incubation on ice. 
Subsequently, the pellet was washed with 500 μL of ice-cold 70% ethanol solution, 
dried and resuspended in 50 μL of EB buffer (10 mM TRIS, pH 8.5). 
3.1.3 Preparation of plasmid DNA 
Routine plasmid preparations were carried out according to the alkaline lysis with 
SDS procedure.141 5 mL of LB medium (supplemented with the respective antibiotic) 
was inoculated with a single colony and grown overnight. 2 mL of the stationary-
phase culture were harvested by centrifugation (13,000 rpm, 1 min) and the cell 
pellet was resuspended in 300 μL of P1 buffer (50 mM TRIS, 10 mM EDTA, pH 8, 
RNAse A 100 μg/mL). 300 μL of P2 buffer [0.2 M NaOH, 1% (w/v) SDS] were 
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added to the cell suspension. The tube was mixed gently by inversion and 
incubated at RT for 5 min. Subsequently, 300 μL of P3 buffer (2.55 M potassium 
acetate, pH 4.8) were added, the content was mixed by inversion and centrifuged at 
RT for 15 min. The cleared supernatant (approx. 800 μL) was transferred into a new 
tube, where 700 μL of ice-cold isopropanol were added. The plasmid DNA was 
pelleted by centrifugation (13,000 rpm, 30 min, 4 °C) and washed once with 300 μL 
of cold 70% ethanol. Finally, the pellet was dried at 42 °C and resuspended in 50 μL 
of ddH2O. 
For sequencing purposes, high-purity plasmid preparations were carried out 
according to the Sigma GenElute HP Plasmid Miniprep kit manual. 
3.1.4 PCR-based gene amplification  
Target genes were amplified from genomic DNA using the primers listed in Table 
2.3, with Phusion High-Fidelity DNA Polymerase, following the manufacturer’s 
protocol for GC-rich DNA templates (5% DMSO final concentration). PCR 
fragments were purified from agarose gel slices, according to the instructions of the 
QIAquick Gel Extraction kit. 
PCR fragments aimed at designing “markerless” gene deletions in R. jostii RHA1 
were created by joining two ∼1500 bp PCR products through splicing overlap 
extension (SOE) PCR.142 First, the two amplicons flanking the desired gene mutation 
were amplified from the chromosome template using two pairs of primers P1, P2 
and P3, P4. Then, because of the overlapping flanks of the P2 and P3 primers, the 
resulting in-frame deletion fragment (which still maintains the 5' and the 3' ends and 
the frame shift of the deleted gene) was obtained by combining the two PCR 
reactions (Figure 3.1). 
 
Figure 3.1 Scheme for the creation of in-frame gene deletion PCR fragments using splicing 
overlap extension (SOE) PCR. First, two PCR fragments, flanking the desired mutation, are 
amplified using two primer pairs. Then, the resulting PCR products are mixed and further 
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amplified resulting in the desired deletion fragment, which is subsequently cloned into the 
appropriate plasmid. 
3.1.5 Vector construction 
Purified PCR products were digested with the corresponding restriction 
endonucleases and cloned into their respective digested vector using T4 DNA 
ligase. Ligation products (1:3 plasmid to insert molar ratio) were used to transform 
(25 kV/cm-1 pulse, 200 Ω resistance, 25 μF capacitance) electrocompetent E. coli 
TOP10 cells. Transformants were plated and selected on LB-agar plates 
supplemented with the corresponding antibiotic. The correct fragment insertion was 
verified by analytical plasmid restriction and by dideoxy sequencing (GATC, 
Kostanz, Germany). Finally, the correct constructs were used to transform E. coli 
BL21 (DE3) or S17-1 strains. An overview of the constructs is given in Table 3.1. 
Table 3.1 Overview of the plasmids created and used in this study. 
constructs for protein expression  constructs for Rhodococcus mutagenesis 
name insert size His-tag  name insert size 
pET28a::dhbE 1655 bp N-term  pK18mobsacB::RHA1∆rhcB 3354 bp 
pET28a::rhcE 245 bp C-term  pK18mobsacB::RHA1∆dhbE 3263 bp 
pET28a::rmo 1350 bp N-term  pK18mobsacB::RHA1∆rmo 3176 bp 
pET28a::rft 939 bp N-term  pK18mobsacB::RHA1∆rft 3299 bp 
pCB28a::cchA128 954 bp N-term    
 
3.1.6 Construction of Rhodococcus mutants 
Rhodococcus “markerless” gene deletion mutants were generated according to the 
protocol described by Van der Geize et al.143 This approach employs the 
transformation of the recipient Rhodococcus strain with the pK18mobsacB plasmid129 
carrying the desired mutation, via a conjugation step from the donor E. coli S17-1 
strain.139 A double selection strategy, carried out in a two-step procedure, allows the 
selection of the desired deletion mutant (Figure 3.2). In the first step, the clones that 
have integrated the suicide plasmid within the chromosome (through a 
intermolecular cross-over) are selected for the presence of the positive marker (i.e. 
the resistance to kanamycin). Subsequently, the transconjugants are propagated to 
allow the second rare recombination event (the intramolecular cross-over) and are 
selected by plating on counter-selective sucrose-supplemented medium. Under 
these conditions, the growth is only possible when the sacB marker was lost, which 
can further be distinguished by PCR using primers flanking the desired mutation. 
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Figure 3.2 Overview of the double selection strategy used for the generation of Rhodococcus 
mutants. Upon transformation of the wild-type strain with the mutagenic plasmid, an 
intermolecular cross-over between one of the two homologous regions flanking the mutation 
occurs, integrating the plasmid into the chromosome. The transformants are then selected 
with the kanR resistance marker. To allow the second rare intramolecular cross-over, the 
transconjugants are allowed to grow without antibiotic and subsequently selected by plating 
on counter-selective sucrose-supplemented medium. The second cross-over event, which 
ensures the correct gene plasmid excision (with the loss of the sacB marker) and results in the 
desired gene deletion, have to occur on the second homologous flanking region. 
R. jostii RHA1 cells were grown on LB plates supplemented with nalidixic acid for 5 
days, harvested, and resuspended in 2 mL of fresh LB broth. The same procedure 
was repeated with the overnight plates of derivative mutagenic E. coli S17-1 strains, 
additionally grown at RT for further 24 h. 750 μL of each cell suspension were 
mixed, incubated briefly at RT, pelleted, and resuspended in 2 mL of LB broth. 
200 μL were spread on LB and incubated overnight at 30 °C. The following day, 
cells were harvested and resuspended in 2 mL of LB broth. Aliquots (150 μL each) 
were successively spread on LB plates supplemented with nalidixic acid and 
kanamycin and incubated at 30 °C for three days, until only Rhodococcus colonies 
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appeared. Transconjugants were grown in liquid medium and vector integration 
was checked by PCR of the kanamycin cassette and by replica plating on LB 
supplemented with kanamycin, or kanamycin and 10% sucrose. To force plasmid 
excision, single integrant colonies were inoculated in LB broth and subsequently 
plated on LB supplemented with 10% sucrose and grown at 30 °C until new colonies 
appeared. To confirm correct plasmid excision, single clones were tested for 
kanamycin sensitivity by replica plating and by PCR using different primer pairs: 
for the kanamycin cassette, for a flanking region and for the deleted gene. 
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3.2 Expression and purification of recombinant proteins 
3.2.1 Gene expression 
5 mL of an overnight culture of E. coli BL21 (DE3) carrying the desired expression 
construct was diluted inside a 2 L baffled flask containing 500 mL of fresh LB 
medium supplemented with 50 μg/mL kanamycin. Cells were grown at 25 °C, 
under continuous shaking at 230 rpm, until OD600 ~0.5 was reached. Gene 
expression was induced with IPTG (50 μM), followed by incubation at 25 °C for 4 h. 
Cells were harvested by centrifugation (6000 rpm, 15 min, 4 °C), resuspended in 
HEPES A buffer (50 mM HEPES, 300 mM NaCl, pH 8) and stored at -20 °C until 
further processing.  
3.2.2 Protein purification 
The frozen cell pellet was thawed on ice and lysed via French press. After a 
centrifugation step (17,000 rpm, 4 °C, 30 min), the cleared lysate was sterile-filtered 
and applied to a Ni-NTA IMAC column (equilibrated with HEPES A buffer) using a 
ÄktaPrime system with a flow rate of 0.8 mL/min. The elution was carried out 
using a linear gradient from 3 to 50% HEPES B buffer (50 mM HEPES, 250 mM 
imidazole, 300 mM NaCl, pH 8) over 30 min, followed by a linear increase to 100% B 
in 10 min at a flow rate of 1 mL/min, harvesting 2 mL fractions. Elution was 
monitored at 280 nm and protein-containing fractions were checked by qualitative 
Bradford assay144 and further analyzed by SDS-PAGE. Pooled fractions were 
dialyzed against 25 mM HEPES, 100 mM NaCl, pH 7.5 buffer, and concentrated 
with Amicon Ultra-15 concentrators.  
3.2.3 Protein quantification 
The final concentration of the overproduced and purified protein was determined 
by Bradford colorimetric assay using a BSA calibration curve. Protein aliquots were 
flash-frozen in liquid nitrogen and stored at -80 °C. 
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3.3 Analytical methods 
3.3.1 HPLC-MS 
High performance liquid chromatography (HPLC) was used as a standard 
methodology for the characterization of compounds based on the retention time on 
a chromatography column. Reversed-phase (RP) chromatography relies on the 
hydrophobic interaction between compounds and the non-polar stationary phase of 
the column (porous graphitic carbon or C8 or C18 coated silica gel). The elution of the 
compounds is mediated employing a gradient with methanol or acetonitrile, which 
shifts the interaction of the analyte for the column towards the mobile phase. The 
retention time of the compounds is monitored by UV-vis detection. The mobile 
phases were routinely supplied with either 0.1% TFA, or 0.05% formic acid, or 
20 mM NFPA as ion pairing reagents to improve chromatographic separation and 
electrospray mass ionization (ESI-MS) of the liquid compounds at atmospheric 
pressure. Routine mass-spectrometry (MS) analysis were carried out on an Agilent 
1100 MSD system. Acquisition of high resolution MS data and CID fragmentation 
analysis of rhodochelin were carried out on a Thermo Electron LTQ-MS Fourier 
transform ion cyclotron resonance mass spectrometer (FTICR-MS). Protein mass 
fingerprinting of tryptic digests and measurements of whole proteins were carried 
out on a Applied Biosystem API QStar Pulsar i system. 
3.3.2 Peptide mass fingerprinting 
The identity of recombinant proteins was verified by peptide mass fingerprinting. 
Gel bands of the correct molecular mass were excised after SDS-PAGE and 
incubated with 200 μL of wash solution [200 mM NH4HCO3, 50% (v/v) acetonitrile] 
for 30 min at 37 °C. The solvent was subsequently removed in a speed-vac manifold 
to complete dryness (37 °C, 30 min). In-band tryptic digestion was carried out by 
addition of 20 μL of a trypsin solution (0.02 μg/μL trypsin, 10% NH4HCO3, 10% 
acetonitrile, pH 8.1) at 37 °C for 45 min. The excess of trypsin was removed, 
followed by an additional incubation period of 16 h. Peptide fragments were eluted 
with 25 μL of a diffusion solution [1% (v/v) TFA, 10% acetonitrile, pH 8.1] and 
sonicated at RT for 45 min. The samples were analyzed on a nanospray-ESI-qTOF-
MS system and the subsequent comparison of the peptide mass fingerprint with the 
MASCOT database allowed the correct protein identification. 145,146 
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3.3.3 HPLC-ESI-qTOF-MS 
The apo-, holo-, and the 2,3-DHB-loaded ArCP RhcE was analyzed by HPLC‐MS 
using a QStar Pulsar i qTOF‐MS coupled to a HPLC system equipped with a C4 
Nucleosil guard column (Macherey & Nagel, 10 x 3 mm, pore diameter of 300 Å, 
particle size 5 μm) with the following conditions: solvent A (water + 0.45% formic 
acid), solvent B (acetonitrile + 0.45% formic acid), flow rate 0.2 mL/min, 
temperature 45 °C with a gradient of 10‐95% solvent B over 10 min, the gradient 
was then held for 7 min. 
3.3.4 Natural product isolation 
For the isolation of rhodochelin, R. jostii RHA1 was grown for two days in LB 
medium. Cells were harvested, washed once and resuspended in an equal amount 
of M9 medium. A 1/100 aliquot was used to inoculate fresh minimal medium (in 
polycarbonate flasks), and cultures were grown for two days, until a CAS positive 
reaction of the supernatant was observed.147 The culture supernatant was extracted 
with 5 g/L of XAD-16 resin for 2 h, and after a washing step, the adsorbed 
compounds were eluted with methanol and immediately concentrated under 
vacuum to dryness. The eluate was resuspended in 2 mL of water and analyzed on 
an Agilent 1100 HPLC system equipped with a Nucleodur C8(ec) column 125 × 2 
mm, and coupled to an ESI-MS detector, utilizing the solvent gradient water + 
0.05% formic acid (solvent A) and methanol + 0.04% formic acid (solvent B), with a 
linear gradient from 0% to 20% B within 40 min, followed by a linear increase to 
95% B in 5 min and holding B for an additional 5 min. The flow rate was set to 0.3 
mL/min and the column temperature to 40 °C. The gradient was also used to 
analyze comparative extractions of R. jostii RHA1 mutants. Large-scale purification 
was carried out by scaling-up the described protocol for 5 L cultures. The dried 
eluate was dissolved in 10 mL of water and separated on a preparative Agilent 1100 
preparative HPLC system equipped with a Nucleodur C8(ec) 250 × 21. Elution was 
performed with the same gradient described previously, using 215 and 280 nm as 
wavelengths for detection and a flow rate of 16 mL/min. Siderophore-containing 
fractions were analyzed via CAS assay and ESI-MS. Positive fractions were pooled 
according to their respective m/z, lyophilized, and subjected to further analysis. 
3.3.5 UV-vis spectroscopy 
UV-vis spectra were recorded on an Ultrospec 3000 (Pharmacia) spectrophotometer. 
Wavescan measurements were performed within a wavelength range of 200-800 nm 
and a scan rate of 750 nm/min. Absorption spectra of rhodochelin and holo-
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rhodochelin as well as the apo- and holo-rhodochelin tripeptide were recorded in 
water at a final concentration of 400 μM. holo-complexes were obtained by 
incubating rhodochelin or the tripeptide (400 μM) with aqueous FeCl3 (400 μM) for 
10 min at RT prior to the scan. Extinction coefficients were derived from the UV-vis 
spectra. The following values were obtained. holo-rhodochelin: λmax 330 nm, ε = 
3842.5 M-1 cm-1, λmax 395 nm, ε = 2205.0 M-1 cm-1, λmax 525 nm, ε = 1567.5 M-1 cm-1. 
holo-rhodochelin tripeptide: λmax 327 nm, ε = 3372.5 M-1 cm-1, λmax 397 nm, ε = 1430.0 
M-1 cm-1, λmax 580 nm, ε = 1567.5 M-1 cm-1. 
3.3.6 IR-spectroscopy 
Purified rhodochelin in a KBr disk was subjected to FT-IR-spectroscopy on a 
Magna-IR 750 spectrometer (Nicolet). Main signals are the following: ν = 3367.2, 
1749.5, 1660.5, 1586.1, 1534.1, 1448.0, 1381.8, 1204.0, 1137.4, 1066.9, 878.9, and  
748.0 cm-1. 
3.3.7 NMR-spectroscopy 
NMR-spectroscopic structure elucidation of rhodochelin was carried out in 
collaboration with Dr. Xiulan Xie (Department of chemistry - NMR facility, 
Philipps-Universität Marburg). About 8 mg of rhodochelin were dissolved in 0.7 mL 
of H2O/D2O (9:1). Measurements were carried out on a Bruker AV600 spectrometer 
with an inverse broadband probe installed with z gradient. The one-dimensional 
spectra 1H and 13C, the homonuclear two-dimensional spectra DQF-COSY, TOCSY, 
NOESY, and ROESY, the 1H-13C HSQC and HMBC, and the 1H-15N HSQC spectra 
were recorded with standard pulse programs at 283 K. The TOCSY spectrum was 
recorded with a mixing time of 80 ms, whereas NOESY and ROESY spectra were 
taken at 150 and 300 ms mixing times. The 1D spectra were acquired with 65,536 
data points, whereas 2D spectra were collected using 4096 points in the F2 
dimension and 512 increments in the F1 dimension. For 2D spectra, 16-32 transients 
were used, while the 13C spectrum was recorded with 12 K scans. The relaxation 
delay was 2.5 s. The 1H chemical shifts were referenced to 4,4-dimethyl-4-
silapentane sodium sulfonate (DSS) in H2O/D2O (9:1) at 283 K externally, whereas 
those of 13C and 15N were referenced with spectrometer default calibration. The 
spectra were processed with Bruker Topspin 2.1. 
3.3.8 Assignment of amino acid stereochemistry via FDAA-derivatization 
Assignment of the amino acid stereochemistry was achieved through rhodochelin 
total acid hydrolysis followed by derivatization with Nα-(2,4-dinitro-5-
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fluorophenyl)-L-alaninamide (FDAA, Marfey’s reagent).148 Purified rhodochelin 
(3.76 mg) was hydrolyzed in 400 μL of 6 M HCl at 99 °C and 1000 rpm for 24 h. The 
lyophilized hydrolysate was resuspended in 50 μL of 1 M NaHCO3, and 10 μL of 
this solution was added to 170 μL of 1% FDAA solution in acetone. The 
derivatization reaction was carried out for 1 h at 37 °C and terminated by addition 
of 20 μL of 1 M HCl. FDAA standard derivatives of amino acids (L/D-Thr, L/D-Orn, 
L-hOrn) were prepared by incubation of 25 μL of 50 mM amino acid solution with 
50 μL of 1% FDAA solution and 10 μL of 1 M NaHCO3 for 1 h. After lyophilization, 
all the products were resuspended in 200 μL of 1:1 water:acetonitrile solution prior 
to injection (10 μL) into a HPLC-MS system equipped with a Synergi Fusion RP-80 
250 × 2.0 mm column utilizing the following solvent gradient: 0-30 min, 0-30% 
buffer A (10 mM ammonium formate, 1% methanol, 5% acetonitrile, pH 5.2) into 
buffer B (10 mM ammonium formate, 1% methanol, 60% acetonitrile, pH 5.2), 
followed by a linear increase to 95% buffer B in 2 min and holding 95% buffer B for 
an additional 5 min. The flow rate was set at 0.3 mL/min and the column 
temperature at 25 °C. Elution was monitored in single ion mode. 
3.3.9 Analytical size-exclusion chromatography 
Size-exclusion chromatography was employed to determine the quaternary 
structure of the recombinant Rmo and Rft. 25 μL of a 50 μM Rmo or Rft solution was 
analyzed using a Superdex 200 5/150 GL column combined with an ÄktaPurifier 
system (Amersham Pharmacia Biotechnology) equilibrated with 25 mM TRIS 150 
mM NaCl pH 8 buffer. Protein elution was monitored at 280 nm. Aldolase (158 
kDa), ovalbumin (43 kDa), ribonuclease (13.7 kDa) and aprotinin (6.5 kDa) were 
used as standards to determine the molecular weight of the proteins in solution. 
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3.4 Chemical synthesis 
3.4.1 Synthesis of L-δ-N-hydroxylornithine (L-hOrn)‡ 
 
Figure 3.3 Reaction scheme of the synthesis of L-δ-N-hydroxyornithine (L-hOrn). 
The synthesis of L-δ-N-hydroxyornithine was accomplished through an indirect 
oxidation approach, as reported by Y.-M. Lin and M. J. Jones (Figure 3.3).149 
 
Step 1. Synthesis of the imine intermediate. 
2 g (8.6 mmol) of the Nα-Boc-protected L-ornithine 3.3.1 was added to a solution 
composed of 0.51 g KOH (9.0 mmol) dissolved in 17 mL of methanol. 0.92 mL 
benzaldehyde (9.0 mmol) and 3 Å molecular sieve were added and the solution was 
gently stirred over night at room temperature. Subsequently, the resin was filtered 
out and washed with methanol, whereas the filtrate was evaporated under reduced 
pressure resulting in a yellow foam corresponding to the imine 3.3.2. 
                                                                  
‡ The two non-proteinogenic amino acids L-δ-N-hydroxyornithine (L-hOrn) and L-δ-N-formylornithine 
(L-fOrn) were kindly provided by Dr. Verena Helmetag and their synthesis was previously published 
in the PhD thesis “V. Helmetag, Biochemische und strukturelle Untersuchungen der Biosynthese 
unnatürlicher Aminosäuren als Bausteine nicht-ribosomaler Peptide, Marburg, 2009”. The synthesis of 
the two amino acids herein presented refers to that work, and it has only been included to improve the 
the sake of completeness. 
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Step 2. Oxidation of the imine 3.3.2 to oxaziridine. 
2.2 g of the imine 3.3.2 (7.0 mmol) was dissolved in 13 mL of methanol and the 
solution was cooled to 0 °C. Then, a solution of 1.2 g of meta-chloroperbenzoic acid 
(7.0 mmol) in 5 mL of methanol was added over 15 min. The reaction was kept at 0 
°C and allowed to proceed for 1 h, under continuous stirring. The resulting 
precipitate was filtered, washed with methanol and dried under reduced pressure. 
Subsequently, the solid compound was dissolved in 34 mL of a 1:1 ddH2O:ethyl 
acetate solution, acidified to pH 2 with HCl 1 M and extracted with ethyl acetate. 
The recovered organic phases were washed with saturated NaCl solution, dried 
with Na2SO4 and concentrated under reduced pressure, resulting in the 
corresponding oxaziridine 3.3.3. 
 
Step 3. Synthesis of the stable nitrone intermediate 3.3.3. 
The unpurified oxaziridine precursor 3.3.3 was dissolved in 10 mL of trifluoroacetic 
acid and, after the addition of 10 mL of CH2Cl2, the reaction mixture was stirred for 
1 h at room temperature. The volatile compounds were removed by evaporation 
and the resulting residue was dissolved in 30 mL of ethyl acetate. A solution of 
diisopropyethylamine in THF was added until pH 8-9 was reached. The reaction 
was cooled at 0 °C and allowed to proceed for 1 h, resulting in a pale-yellow 
precipitate which was filtered and freeze-dried. The crude product was dissolved in 
10 mL of ddH2O and purified by HPLC using a preparative C18-column equilibrated 
with ddH2O (0.1% TFA, solvent A). The compounds were eluted with a 20 mL/min 
flow rate, performing the following acetonitrile (0.1% TFA, solvent B) gradient: 0 % 
B for 5 min, 0-30 % B in 30 min and 30-95 % in 3 min. The elution was monitored at 
215 nm and the resulting fractions were identified by ESI-MS, pooled and 
lyophilized, resulting in 945 mg of the corresponding nitrone 3.3.4. 
 
Step 4. Conversion of the nitrone 3.3.4 to the hydroxylamine 3.3.5. 
The final stage of the synthesis of L-hOrn was carried out from small quantities of 
the stable nitrone, as this intermediate is more stable than the final product. 0.1 g of 
the nitrone 3.3.4 (0.4 mmol) was diluted in 0.55 mL of hexane. Subsequently, 1.1 mL 
of 0.5 M HCl and 0.27 mL of TFA were added. The mixture was heated at 60 °C 
under reflux for 15 min. The volatile compounds were removed under reduced 
pressure and the resulting yellowish oil was mixed with 1.1 mL of CH2Cl2 and 1.62 
mL of HCl 1 M. The mixture was heated at 40 °C to allow the compounds to 
dissolve and mixed for 40 min at RT. The organic phase was removed, whereas the 
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water phase was extracted with CH2Cl2 and hexane and concentrated, yielding L-δ-
N-hydroxyornithine 3.3.5, as a yellowish foam.  
3.4.2 Synthesis of L-δ-N-formylornithine (L-fOrn) 
 
Figure 3.4 Reaction scheme of the synthesis of L-δ-N-formylornithine (L-fOrn). 
The synthesis of L-δ-N-formylornithine was carried out according to the established 
protocol described by R. G. Jones (Figure 3.4).150 
 
Step 1. Formylation of the side chain of the N-α-Fmoc-protected amino acid. 
391 mg of N-α-Fmoc-protected L-ornithine 3.4.1 (1 mmol) was added to 1 mL of 98% 
formic acid and the mixture was heated until dissolved. After the addition of a hot 
solution of sodium formate (75 mg, 1.1 mmol) in 98% formic acid, the mixture was 
allowed to cool. Subsequently, 225 μL (2.4 mmol) of acetic anhydride was added 
and the reaction mixture was heated at 70 °C for 30 min. The excess of formic and 
acetic acid was removed under reduced pressure and the remaining residue was 
dissolved in 5 mL of acetone and the solvent further evaporated. 
 
Step 2. Removal of the Fmoc-protecting group. 
The formylated compound 3.4.2 was dissolved in 10 mL of DMF. 2.5 mL (25 mmol) 
of piperidine was added dropwise at 0 °C and the solution was stirred for 1 h at 
room temperature. The resulting product 3.4.3 was purified via flash-
chromatography on a silica-gel column equilibrated with a 4:1 solution of 
methanol:ddH2O. During the chromatography, the water content of the mobile 
phase was gradually increased to 100%. The product-containing fractions were 
analyzed by thin-layer chromatography (mobile phase methanol:ddH2O 4:1) and 
freeze-dried. 
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3.4.3 Synthesis of the formyl-donor cosubstrate intermediate N5,N10-methenylH4F 
 
Figure 3.5 Reaction scheme of the synthesis of the formyl-donor cosubstrate intermediate 
N5,N10-methenylH4F. 
The formyl-donor cosubstrate intermediate N5,N10-methenylH4F 3.5.2, required for 
the generation of the N10-fH4F donor, was synthesized according to a protocol 
previously published, with minor modifications (Figure 3.5).151 
In the first half-reaction, 7 mg of N5-fH4F 3.5.1 was dissolved in 1.5 mL of water and 
was converted to N5,N10-methenylH4F 3.5.2 by drop-wise addition of 0.1 M HCl, 
until pH 1.9 was reached. The solution was then brought to a final volume of 2.2 mL 
using water and further incubated at room temperature for 4 h. The formation of 
N5,N10-methenylH4F resulted in a color change of the solution, from colorless to pale 
yellow, and was further verified via ESI-MS measurements. The obtained 
compound (~ 6 mM final concentration) was stored at -20 °C until further usage. 
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3.5 Biochemical methods 
3.5.1 ATP/PPi exchange assay 
The substrate specificity of the stand-alone DhbE domain was investigated by 
ATP/PPi exchange. The reversibility of the 2,3-DHB-AMP formation is exploited to 
incorporate 32PPi into ATP in the backward reaction (Figure 3.6).152,153 
 
Figure 3.6 The reversible adenylation reaction exploited to investigate the substrate 
specificity of the adenylation domain DhbE. 
Following incubation, the radioactively-labeled ATP is adsorbed on charcoal and 
the subsequent analysis of the total radioactivity count allows for a relative 
comparison of the incorporation rates among different amino acid substrates.  
A 100 μL reaction was composed of the following: 50 mM Tris HCl pH 7.5 buffer, 10 
mM MgCl2, 1 mM DTT, 1 mM ATP, 5 mM Na4P2O7, 10 mM amino acid. Prior to 
initiation of the reaction with 2 μM recombinant DhbE, 20 μL of a Na432P2O7 solution 
(approx 100,000 counts) was added. The reaction was incubated at 25 °C for 30 min 
and subsequently quenched with 750 μL of charcoal suspension [100 mM Na4P2O7, 
600 mM HClO4, 1.6% (w/v) charcoal]. After a washing step with water, the 
resuspended charcoal was combined with 3 mL of scintillation fluid, prior to 
counting with a Packard Tri-carb 2100TR liquid scintillation analyzer. All reactions 
were performed in triplicate. 
3.5.2 Fluoresceinyl-CoA phospopantetheinylation assay 
Purified recombinant PCP-domains are generally recovered in the inactive apo form, 
due to inefficient E. coli priming reaction (the transfer of the ppan group from the 
CoA donor to the conserved Ser of the core-T motif) ppan transferases during the 
heterologous production.153 The in vitro conversion of the PCP-domain, from the 
inactive apo- to the active holo-enzyme, is catalyzed by the promiscous B. subtilis Sfp, 
which displays a broad substrate tolerance and is therefore suitable to catalyze the 
transfer of a different range CoA-derivatized substrates to different PCP-
domains.154,155 The use of fluoresceinyl-CoA, as a donor substrate, provides a direct 
measure of priming efficiency regarding the recombinant PCP (Figure 3.7). A typical 
assay was composed of 10 μM RhcE, 5 μM Sfp, 0.1 mM fluoresceinyl-CoA, 10 mM 
MgCl2, in 50 mM TRIS buffer, pH 7.5. The reaction mixture was incubated at 37 °C 
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for 30 min and subjected to SDS-PAGE analysis. The labeled protein was visualized 
under UV-light, and the gel was subsequently stained with Comassie dye. Control 
reactions were carried out omitting Sfp. 
 
Figure 3.7 Sfp-mediated RhcE priming with fluoresceinyl-CoA. 
3.5.3 RhcE priming and coupled reaction with DhbE  
In order to verify the transfer of the activated 2,3-DHB-AMP to its cognate RhcE 
PCP, a two-step reaction assay was carried out (Figure 3.8). The first half-reaction 
required the priming of RhcE with the ppan arm.  
 
Figure 3.8 Reaction scheme of the coupled assay of DhbE and RhcE. (A) RhcE priming in the 
presence of Sfp, Mg2+ and CoA. (B) DhbE and RhcE coupled assay, where the 2,3-DHB 
substrate is first activated by DhbE and subsequently on the cognate primed ArCP RhcE. 
A 50 μL mixture contained 50 μM RhcE, 5 μM Sfp, 0.5 mM CoA, 10 mM MgCl2, in 50 
mM TRIS buffer, pH 7.5 and was incubated at 37 °C for 30 min. Subsequently, 5 μM 
DhbE, 1 mM ATP and 1 mM 2,3-DHB were added to a final volume of 100 μL. The 
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mixture was further incubated at 37 °C for 30 min and analyzed via HPLC-ESI-TOF-
MS. 
3.5.4 Rmo-mediated L-Orn hydroxylation 
 
Figure 3.9 Reaction scheme of the Rmo-catalyzed FAD/NADPH-dependant δ-amino L-Orn 
hydroxylation. 
The typical NMO Rmo is responsible for the hydroxylation of the δ-amino group of 
L-Orn, in the presence of the FAD cofactor and NADPH as a reducing cosubstrate 
(Figure 3.9). 50 μL reaction contained the following: 100 mM TRIS pH 8, 1 mM L-
Orn, 2 mM NADPH, 25 μM FAD and 20 μM Rmo. Reaction controls were carried 
out in the absence of cosubstrate NADPH or enzyme. Different amino acids were 
tested as substrates to elucidate Rmo specificity. Reactions were incubated for 4 h at 
30 °C and stopped by the addition of 2 μL formic acid and analyzed via HPLC-MS.  
Determination of the kinetic parameters for the Rmo-dependent hydroxylation was 
performed maintaining the NADPH and FAD concentration at 0.5 mM and 20 μM, 
respectively and varying L-Orn substrate concentration between 0.10 and 20 mM. 
Reactions were started by the addition of Rmo to a final concentration of 5 μM and 
stopped with 2 μL of formic acid after 2.5 min incubation. Product formation was 
quantified via HPLC-MS, using a L-hOrn calibration curve. All reactions were 
perfomed in triplicate. 
3.5.5 In situ N10-fH4F conversion and L-hOrn formylation assay 
 
Figure 3.10 Reaction scheme of the Rft-catalyzed δ-amino L-hOrn formylation. 
The N10-fH4F-dependent enzyme Rft catalyzes L-hOrn formylation (Figure 3.10). The 
reaction assay was set-up in a 50 μL volume, in the presence of 50 mM HEPES 
buffer pH 7.5, 1 mM L-hOrn, 1.5 mM N5,N10-methenylH4F and 25 μM Rft (or CchA). 
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Prior to the addition of the amino acid and the enzyme, the cosubstrate intermediate 
was pre-incubated in the reaction buffer at 30 °C for 30 min to permit the final pH-
dependent conversion to N10-fH4F. After the addition of the substrate and the 
enzyme, the reaction was allowed to proceed for 4 h at 30 °C, then stopped by the 
addition of 2 μL formic acid and analyzed via HPLC-MS. 
The kinetic parameters for Rft-mediated transformylation were determined by 
maintaining the N5,N10-methenylH4F concentration at 1.5 mM, and varying the 
L-hOrn concentration between 0.25 and 15 mM. Reactions were started by adding 
Rft to a final concentration of 5 μM and stopped with 2 μL formic acid after 5 min 
incubation. Product formation was quantified via HPLC-MS. All reactions were 
performed in triplicate. 
3.5.6 Coupled L-Orn hydroxylation and formylation 
A coupled hydroxylation and formylation assay was established to identify an 
enzymatic pathway for the generation of the iron-coordinating L-fhOrn. The 
reaction assay was performed in HEPES buffer, and prior to the addition of the 
amino acid and the enzymes, the cosubstrate intermediate was pre-incubated in the 
reaction buffer at 30 °C for 30 min to permit the final pH-dependent conversion to 
N10-fH4F. A typical assay in HEPES buffer contained 1 mM L-Orn, 2 mM NADPH, 
1.5 mM N5,N10-methenylH4F, 40 μM FAD, 25 μM Rmo and 25 μM Rft. The reaction 
was carried out for 4 h, stopped with 2 μL formic acid and analyzed via HPLC-MS. 
3.5.7 HPLC-MS analysis of the L-Orn tailoring reactions 
All Rmo- and Rft-catalyzed assays were analyzed by HPLC-MS on a Hypercarb 
column equilibrated with 20 mM aqueous NFPA (solvent A). Acetonitrile (solvent 
B) was used to employ a linear gradient from 0% to 15% B within 25 min, followed 
by a linear increase to 100% B in 2 min and finally holding B for an additional 3 min. 
The flow rate was set to 0.2 mL/min and the column temperature to 20 °C. The 
elution was monitored in single-ion mode.  
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3.6 Bioinformatic Methods 
Web-browser-based and stand-alone programs were used to analyze nucleic acid 
and protein sequences. Genome analysis and operon visualization was performed 
with Artemis.156 Given a genome sequence, ANTIsmash allowed a rapid 
identification of the major known secondary metabolites gene clusters.157 The 
prediction of the adenylation domain substrate specificity was carried out with 
NRPSpredictor and its updated version NRPSpredictor2.40,158 These tools analyze the 
physico-chemical properties of the residues surrounding the A-domain substrate 
binding pocket, extending the ten amino acid code defined by Stachelhaus et al., and 
thus, improving the overall prediction.39 Sequence-homology searches were 
executed using the BLAST algorithm, and multiple sequences alignments were 
conducted with ClustalW, ClustalO or Muscle.159-162 Genome-BLAST comparisons 
were carried out using Mauve.163 All sequences were retrieved from the NCBI 
database (http://www.ncbi.nlm.nih.gov/). 
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4.1 Isolation and structural characterization of rhodochelin 
4.1.1 Extraction and purification of rhodochelin 
In bacteria, the biosynthesis of siderophores is a tightly regulated event. In order to 
force the microorganism to produce these types of secondary metabolites, R. jostii 
RHA1 was cultivated in M9 minimal medium under iron starvation conditions. The 
production of an iron-scavenging compound was confirmed via chromeazurol S 
(CAS) liquid assay and could be observed two days after the inoculum.147 The 
supernatant was subsequently extracted with XAD-16 resin and analyzed via 
HPLC-MS. As shown in the chromatograms illustrated in Figure 4.1, the application 
of iron-deficient grow conditions resulted in two new major compounds. The first 
one (compound 4.1, retention time, tR 17.6 min) showed a m/z of 572.2201 ([M+H]+), 
whereas the second one (compound 4.2, tR 21.4 min) displayed a m/z of 414.1510 
([M+H]+). 
 
Figure 4.1 (A) HPLC-MS profiles of XAD-16 extracted culture supernatants of R. jostii RHA1 
grown in M9 minimal medium in the absence (red line) or presence (blue line) of Fe3+. The 
absence of ferric iron induces the production of two compounds which elute at tR 17.6 min 
and tR 21.4 min, respectively. (B) Detailed high-resolution mass spectra corresponding to the 
UV signals. 
In order to obtain sufficient amounts of sample material required for structure 
elucidation, the bacterial culture was scaled-up to a volume of 5 L. Preparative 
HPLC showed a similar “two-peak” profile (Figure 4.2). Single fractions were 
analyzed via CAS liquid assay and ESI-MS and subsequently pooled according to 
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their m/z (bioassay-guided fractionation). Subsequent structure elucidation studies 
were performed using the compound 4.1 with a m/z of 572.2, which was obtained 
with a yield of to 13 mg/L. From now on, this compound will be referred to as 
rhodochelin. As will be shown later, comound 4.2 is a degradation product of 
rhodochelin and will thus be referred to as rhodochelin tripeptide. 
 
Figure 4.2 (A) Chromatogram of the preparative HPLC purification of the XAD-16 extracted 
culture supernatant of R. jostii RHA1 grown in iron-limited conditions. (B) HPLC-MS analysis 
and corresponding mass spectra of the purified compound 4.1 (m/z 572.2 [M+H]+). (C) 
HPLC-MS and corresponding mass spectra of the purified compound 4.2 (m/z 414.1 [M+H]+, 
m/z 436.1 [M+Na]+). 
4.1.2 MSn analysis of rhodochelin composition 
To acquire additional information about the individual building blocks of 
rhodochelin and their connectivity, collision induced dissociation (CID) 
experiments were carried out. MS2 fragmentation of rhodochelin with a m/z of 572.2 
([M+H]+) revealed a major fragment ion with a m/z of 396.1402 ([M+H]+, calculated 
396.1401), due to the loss of a δ-N-formyl-δ-N-hydroxyornithine (fhOrn) moiety. 
MS3 experiments of the aforementioned fragment ion led to the formation of two 
additional ions with a m/z of 177.0870 and m/z of 238.0711. The first one could easily 
be associated with a second fhOrn residue ([M+H]+, calculated 177.0870), whereas 
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the second one is indicative of a charged DHB-Thr dipeptide ([M]+, calculated 
238.0710) (Figure 4.3). In summary, the fragmentation studies led to the conclusion 
that rhodochelin consists of two fhOrn moieties, one 2,3-DHB residue, and one 
moiety of Thr (directly connected to the aryl residue). High resolution MS analysis 
confirmed an exact m/z of 572.2201 ([M+H]+, calculated 572.2198), consistent with 
the molecular mass of a compound with a chemical formula of C23H33N5O12. High 
resolution MS experiments conducted on rhodochelin tripeptide revealed it to be a 
derivative of rhodochelin, lacking the second fhOrn moiety (m/z 414.1510 [M+H]+, 
calculated 414.1507), suggesting that it represents a degradation product of the 
intact rhodochelin molecule.  
 
Figure 4.3 (A) Structure of rhodochelin highlighting the main fragments resulting from CID 
experiments. (B) Gas-phase fragmentation of rhodochelin (MS2) resulted in the formation of a 
major fragment of m/z 396.1402 [M+H]+, indicative of the loss of a fhOrn building block. (C) 
MS3-fragmentation of the former daughter ion gave rise to the formation of a second fhOrn 
ion (m/z 177.0870 [M+H]+) and a third charged fragment of m/z 238.0711 ([M]+) coherent 
with a 2,3-DHB-Thr dipeptide. 
4.1.3 Structure elucidation of rhodochelin via NMR 
On the basis of the knowledge that our target rhodochelin contains one 2,3-DHB, 
one threonine (Thr), and two δ-N-formyl-δ-N-hydroxyornithine (fhOrn) moieties, 
the final structure was determined by NMR spectroscopy (Figure 4.4). The assigned 
1H, 13C, and 15N chemical shifts are listed in Table S1. The 1H spectrum showed two 
doublets at 9.169 and 8.505 ppm for the amide protons of Thr1 and fhOrn2, 
respectively. Two singlets at 7.893 and 7.826 ppm were observed for the formamide 
protons of fhOrn2 and fhOrn3, respectively. A second set of peaks was also observed 
in this region, which corresponds to a minor stereoisomer of the siderophore in 
water at 283 K. Only chemical shifts of the major stereoisomer are listed in Table S1. 
Two cross-peaks were observed in the 1H-15N HSQC spectrum, which verified the 
presence of two amide bonds in the molecule. TOCSY cross-peaks additionally 
confirmed the presence of one threonine and two ornithines. NOE contacts between 
B
120

	
238.0711
m/z180 240 300
[fhOrn+H]+
177.0870
CA
OH
HO
N
H
O
H
O
H
N
O
OH
O
N
OH
OH
O
NH2
N
OH
OH
2
3
8
.0
7
1
1
1
7
7
.0
8
7
0
396.1402
	
396.1402
m/z380 440 500 560
	
573.2238
554.2099
414.1514
-fhOrn
Results 
 57 
the amide proton of Thr1 (NH1) and H4 of 2,3-DHB and NH2 and HR1 were 
observed, which revealed the partial structure 2,3-DHB-Thr1-fhOrn2. Furthermore, 
long-range NOE contacts of Hβ1 and Hγ1 with HR3 were detected. A long-range 1H-
13C correlation was observed between Hβ2 and the carbonyl carbon of fhOrn3. 
Combining all this information about the long-range connections, the presence of an 
ester bond between the carbonyl of fhOrn3 and the side chain hydroxyl of Thr1 was 
established (Figure 4.4), and further verified via IR-spectroscopy (Figure S1). The 
corresponding COSY, ROESY, and HMBC spectra are shown in Figures S2-S4. 
 
 
Figure 4.4 The structure of rhodochelin as determined by NMR. (A) Long-range 1H-13C 
correlations observed in H2O/D2O (9:1) at 283 K: blue arrows indicate intra-residue contacts, 
red arrows indicate long-range inter-residue contacts. (B) NOE contacts observed in 
H2O/D2O (9:1) at 283 K: blue arrows indicate intra-residue contacts, red arrows indicate 
long-range inter-residue contacts. (C) The structure of rhodochelin showing the numbering of 
the four building blocks. 
4.1.4 Assignment of rhodochelin stereochemistry 
The assignment of the amino acid stereochemistry was carried out by derivatization 
of the acid hydrolyzate of rhodochelin with FDAA (Marfey’s reagent).148 The 
derivatized mixture was then subjected to HPLC-MS analysis and compared with 
amino acid standards (L/D-Thr, L/D-Orn, L-hOrn), previously modified with the 
same derivatization reagent. Interestingly, during the acid hydrolization step, the 
loss of formyl moiety from fhOrn occurred, leading to the generation of hOrn. 
Furthermore, the reaction of this latter amino acid with FDAA in acetone resulted in 
the formation of a compound known to be its nitrone derivative, as previously 
reported during the synthesis of ε-N-acetyl-ε-N-hydroxylysine.164 The comparison of 
the HPLC-MS chromatograms and the MS spectra of the derivatized acid 
hydrolysate with the synthetic amino acid standards revealed the sole presence of 
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DNPA-L-Thr and DNPA-L-hOrn as the constituents of the target compound (Figure 
4.5). 
 
Figure 4.5 HPLC-MS profile of the FDAA-derivatized amino acid standards and the 
derivatized products of rhodochelin hydrolysis. (A) Rhodochelin was first hydrolyzed in HCl 
and the lyophilized products of the reaction were derivatized with FDAA. The reaction 
mixture was then analyzed via HPLC-MS and compared with synthetic derivatized amino acid 
standards (the respective retention time and MS-spectrum of each compound is given). (B) 
The chemical structures and the observed MS-spectra of the derivatized amino acid standards 
and the derivatized products of rhodochelin are given. 
4.1.5 Physico-chemical properties of rhodochelin 
In order to determine if rhodochelin and rhodochelin tripeptide possess a 
physiological function as iron chelating compounds, ferric iron complexes of 
rhodochelin and rhodochelin tripeptide were analyzed via UV-vis spectroscopy and 
HPLC-MS. Both compounds retained the capacity to complex Fe3+, which is 
reflected both in the UV-vis spectra and HPLC-MS chromatograms. In particular, 
binding of the ferric ion altered the spectral properties of the siderophore, resulting 
in a shift of the absorption peak from 315 to 330 nm (corresponding to the π→π* 
transition of the catechol group) and in the occurrence of two new absorption peaks 
at 395 and 525 nm, indicative of the ferric-hydroxamate and ferric-catecholate charge 
transfer, respectively.165-167 Furthermore, the chelation of iron induced a strong shift 
in the chromatographic retention, suggesting that a drastic conformational going 
from apo- to holo-rhodochelin occurred, resulting in an altered hydrophilicity, and 
thus behavior, of the complex on the HPLC column (Figure 4.6). HR-MS analysis 
confirmed the identity and the 1:1 stoichiometry of the of ferric-rhodochelin 
complex, having a m/z of 625.1299 ([M-H+Fe3+-3H]+, calculated 625.1302). Besides, 
similar results were also obtained for rhodochelin tripeptide, the ester hydrolysis 
product of the siderophore, recovered during the extraction procedure. The 
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complete UV-vis and HPLC-MS analysis of the apo- and holo-rhodochelin tripeptide 
is shown in Figure S5. 
 
Figure 4.6 (A) HPLC-MS profile of Fe-loaded rhodochelin. (B) UV-vis spectrum of 400 μM 
apo-rhodochelin (blue trace) and holo-rhodochelin (red trace). 
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4.2 Identification of the rhodochelin biosynthetic gene clusters 
4.2.1 Identification of the rhodochelin biosynthetic genes via genome mining 
In order to associate a gene cluster with rhodochelin biosynthesis, a genome-mining 
analysis of the sequenced and annotated genome of R. jostii RHA1 identified three 
gene clusters putatively responsible for assembly, export, and subsequent uptake of 
a peptide siderophore (Figure 4.7).124,168 
 
Figure 4.7 (A) Representation of the linear R. jostii RHA1 chromosome and localization of the 
three gene clusters involved in rhodochelin biosynthesis. (B) Schematic overview of the rhc 
gene cluster A that is responsible for rhodochelin assembly. Cluster C encodes for the 
tailoring enzymes required for the biosynthesis of the non-proteinogenic amino acid L-fhOrn. 
The dhb gene cluster C is responsible for the synthesis of 2,3-DHB. Genes are differently 
colored by proposed function. Putative functions of the proteins encoded within the operons 
are based on BLAST-analysis and are given in the figure. 
The first cluster (cluster A) is composed of six genes and is located in a region 
covering approximately 12 kbp between ORFs RHA1_ ro02318 and RHA1_ro02323: 
these genes have been renamed from rhcA to rhcF. rhcB is the largest gene (7.1 kbp) 
and encodes a typical modular NRPS, composed of two complete modules and a 
terminal thioesterase (TE) domain. Substrate-specificity prediction for the 
adenylation (A) domains suggests a preference for L-Thr for the first module, and L-
Asp for the second module (Table 4.1 and Figure 4.8).39  
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Table 4.1 Comparison of the extracted active-site residues determining the adenylation 
domain specificity of RhcB with known adenylation domains. The substrate prediction for 
each A-domain as well as the product of the NRPS is given, whereas the differences are 
highlighted in red. CDA, calcium-dependent antibiotic. 
A-domain active site residues substrate product 
RhcB-A1 DFWNVGMVHK   
CDA PSI-A2 DFWNVGMVHK L-Thr CDA 
RhcB-A2 DLWGMGAVNK   
CDA PSI-A4 DLTKIGAVNK L-Asp CDA 
 
The protein sequences of rhcA and rhcE show sequence homology to the single 
domains of DhbB found in the bacillibactin (B. subtilis) gene cluster. RhcA has been 
annotated as an isochorismatase (ICL), resembling the N-terminal domain of DhbB, 
whereas RhcE is homologous to the C-terminal aryl carrier protein (ArCP) 
domain.103 The remaining three ORFs located in the cluster are involved in 
siderophore export (rhcD) and uptake: rhcC has been proposed encoding for an 
extracellular Fe3+/hydroxamate binding protein, whereas rhcF encodes for an ABC 
type 2 transporter. 
 
Figure 4.8 Representation of the modular organization of the NRPS RhcB and the stand-alone 
NRPS domains RhcE and DhbE that are responsible for rhodochelin biosynthesis. The NRPS 
RHA1_ro04715 located in cluster 2 is not involved in the biosynthesis of the siderophore. 
Neither its modular organization nor the adenylation domain substrate specificities are in 
accordance with the linear logic of the rhodochelin NRPS assembly line. The domains are 
colored differently by proposed function: grey for condensation (C), red for adenylation (A), 
green for peptidyl carrier protein (PCP), blue for epimerization (E) and orange for the 
thioesterase (TE) domains. The prediction of the substrate specificity of the adenylation 
domains is indicated within the module. 
The absence of genes encoding for tailoring enzymes involved in the biosynthesis of 
the fhOrn moiety led to the identification of a second gene cluster responsible for 
siderophore biosynthesis located in another genomic region. Cluster B is composed 
of eight genes, spanning a DNA region of approximately 25 kbp, located between 
ORFs RHA1_ro04710 and RHA1_ro04717. The largest gene is RHA1_ro04715 (16.7 
kbp) and encodes for a tetramodular NRPS that lacks the terminal TE-domain 
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(substituted by a C-domain). In addition, both the first two modules also contain an 
epimerization domain. This large NRPS gene shows high sequence homology (51% 
identity, 64% similarity) to EtcD, the NRPS responsible for erythrochelin 
biosynthesis, a siderophore isolated from S. erythraea.14,169 The modular organization 
of the NRPS exactly matches EtcD, and, in addition, the comparison of the 
adenylation domain substrate specificity prediction (Table 5.2), together with the 
presence of two tailoring enzymes annotated as a formyltransferase (ORF RHA1_ 
ro04712, renamed rft) and an ornithine monooxygenase (ORF RHA1_ro04716, 
renamed rmo), respectively, led to the hypothesis that this cluster could be 
responsible for the synthesis of a foroxymithine derivative (Figure 5.4).170 In 
addition, the 3' end of rmo overlaps the 5' end of the following ORF (RHA1_ro04717) 
by four nucleotides. Due to the high sequence identity of the latter ORF with MbtH-
like family proteins, it was renamed mbtH.171 Interestingly, this gene is present as a 
single copy in the R. jostii RHA1 genome. ORFs RHA1_ro04710 and RHA1_ ro04711 
are predicted to encode ABC-transporters, while RHA1_ro04713 and RHA1_ro04714 
are thought not to be directly involved in rhodochelin biosynthesis and/or 
transport, as they share homology with hydrolases and diguanilate 
cyclase/phosphodiesterase. Taken together these results support the hypothesis 
that while the rhc cluster is responsible for the synthesis of the catecholate-
hydroxamate siderophore rhodochelin and its export and uptake, the second cluster 
contains tailoring enzymes required for the synthesis of the L-fhOrn building block. 
In addition, cluster B contains the MbtH-like protein that was shown to be an 
essential cofactor for the amino acid activation in some other systems, especially 
under severe growth conditions, such as iron starvation.172,173 
It is important to note that the incorporation of a 2,3-DHB building block into the 
NRPS assembly line of bacillibactin requires its activation as an adenylate:174 this 
reaction is carried out by the aryl acid-activating domain DhbE.35 Previous studies 
reported that the presence of 2,3-DHB moieties within catecholate siderophores 
requires additional genes necessary for its biosynthesis from the chorismate 
precursor.175 In this study, no genes encoding enzymes involved in the chorismate 
pathway have been annotated in the surroundings of both gene clusters, except for 
the ICL RhcA. A BLAST search using DhbE as a query led to the identification of a 
homologue (RHA1_ro04793) in another locus of the R. jostii RHA1 genome (cluster 
C).159 This gene was renamed to dhbE. In addition, two more genes located upstream 
of the adenylation domain, which where previously annotated as an isochorismate 
synthase (dhbC) and a 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase (dhbA), 
have been found, identifying all the enzymes necessary for the biosynthesis of the 
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2,3-DHB moiety from its chorismate precursor.176 A complete bioinformatic 
overview of the gene clusters involved in rhodochelin biosynthesis is presented in 
Table S2. 
4.2.2 Construction of isogenic deletion mutants in R. jostii RHA1 and test for 
rhodochelin activity 
In order to verify the hypothesis of distantly located gene clusters involved in the 
biosynthesis of the same natural product, gene deletion studies in R. jostii RHA1 
were performed. rhcB, dhbE, rmo, and rft were chosen as targets because they were 
considered to be essential for the assembly of the natural product or the 
biosynthesis of its non-proteinogenic L-fhOrn precursor and, at the same time, were 
located in the three different chromosomal loci. Isogenic deletion mutants were 
constructed from the RHA1 wild-type strain employing a markerless in-frame gene 
deletion approach, which has the advantage to avoid any polar effects on 
downstream genes.177 As a result, four new strains were generated: RHA1ΔrhcB, 
RHA1ΔdhbE, RHA1Δrmo, and RHA1Δrft. The correct in-frame deletion was verified 
by PCR amplification using primer pairs flanking the mutation, which resulted in a 
shorter amplicon in the mutant strain (Figure S6). Culture supernatants were 
analyzed for CAS activity, but no strain was capable of producing an iron-chelating 
compound (Figure S7). This result was further confirmed by comparing the HPLC-
MS traces of extracted supernatants, which lacked the “two-peak” profile, typical 
for rhodochelin production (Figure 4.9). 
RHA1Δrmo and RHA1Δrft extracts were furthermore analyzed via extracted ion 
chromatograms (EIC) for masses corresponding to rhodochelin derivatives lacking 
the N-hydroxy or N-formyl groups (data not shown). MS analysis of these 
supernatant extractions confirmed an abolished production of rhodochelin. In 
addition, no foroxymithine derivative has been detected. These results clearly 
demonstrate that these four genes are directly associated with rhodochelin 
biosynthesis, even if they are located in three different genomic regions within the 
bacterial chromosome. 
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Figure 4.9 (A) Comparative HPLC-MS profiles obtained from the extracts of the culture 
supernatants of R. jostii RHA1 wild-type strain and nonproducing rhodochelin mutant strains. 
The single deletion of one of any four genes (which are located in three different 
chromosomal loci) resulted in an abolished rhodochelin production, implying an 
unprecedented cross-talk mechanism. (B) Schematic overview of the genes (and their relative 
location) that have been deleted from the bacterial chromosome. 
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4.3 Biochemical characterization of rhodochelin NRPS assembly-enzymes 
4.3.1 DhbE ATP/PPi exchange 
In order to verify the adenylating activity and the substrate specificity of DhbE, the 
corresponding gene was cloned as an N-terminal His-tag fusion in pET28a(+), 
heterologously produced in E. coli and purified via affinity chromatography. The 
substrate specificity of the purified recombinant enzyme has been tested using 
several amino acids and two aryl acid isomers. In an ATP/PPi exchange assay, 
following 30 min incubation in the presence of an excess of Na432P2O7, DhbE showed 
a distinct preference for its cognate substrate 2,3-DHB, validating the bioinformatic 
prediction (Figure 4.10). 
 
Figure 4.10 (A) SDS-PAGE of purified recombinant DhbE. (B) Relative activities obtained 
from the ATP/PPi exchange assay for DhbE. To test the substrate specificity of the enzyme, 
DhbE was incubated in the presence of an excess of Na4
32P2O7 and the different amino acids 
for 30 min. The reaction was quenched with charcoal and end-point radioactive-ATP was 
measured. Error bars represent standard deviations from three independent measurements. 
4.3.2 Coupled assay of DhbE and RhcE 
A coupled reaction assay was set up in order to verify the ability of the stand-alone 
ArCP holo-RhcE to accept the activated 2,3-DHB-AMP from the previously 
characterized DhbE-catalyzed adenylation reaction (Figure 4.11 A). RhcE was 
expressed as a C-terminal His-fusion protein in pET28a(+), heterologously 
produced in E. coli and purified via affinity chromatography. Initially, the apo-
purified carrier protein was tested for the ability to be converted to its active holo-
form, using the CoA analogue fuoresceinyl-CoA (Fl-CoA). In the presence of the 
phosphopantetheinyl transferase Sfp, the recombinant RhcE could be fluorescently 
labeled, as shown in the SDS-PAGE analysis of the enzymatic mixture under UV-
light (Figure 4.11 B). Therefore, a coupled assay was set up in a similar fashion, in a 
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two-step reaction, the first being the priming of the apo-RhcE with CoA. As shown 
in Figure 4.11 C, the ESI-qTOF-MS measurement of the priming reaction displayed a 
mass shift of 341 Da, consistent with the covalent modification of the catalytically 
active Ser residue with the CoA ppan arm, which is indicative of the conversion 
from apo- to holo-RhcE. When the primed RhcE was incubated in the presence of 
ATP, 2,3-DHB and the stand-alone adenylation domain DhbE, a shift of 476 Da 
occurred, suggesting the transfer of the activated 2,3-DHB-AMP to the free thiol 
group of the ppan arm, thus resulting in RhcE-S-2,3-DHB (Figure 4.11 D).  
  
Figure 4.11 Coupled reaction of DhbE and RhcE. (A) Schematic overview of the conversion 
from apo- to holo-RhcE in the presence of Sfp, CoA and Mg2+ and subsequent coupled assay 
reaction with 2,3-DHB-AMP, catalyzed by DhbE. (B) SDS-PAGE analysis of the fluoresceinyl-
labeled RhcE. When Sfp was present in the mixture, the transfer of the fluorescent group 
from the Fl-CoA donor to the catalytically active Ser residue of the PCP-domain occurred, 
resulting in a fluorescent SDS-PAGE band under UV-light. (C) Deconvoluted ESI-qTOF-MS 
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measurements of the Sfp-catalyzed RhcE priming reaction. The mass shift of 340 Da is 
indicative of the transfer of the ppan arm from the CoA donor to the catalytically active Ser 
residue of the PCP, resulting in the conversion from apo-enzyme to holo-enzyme. (D) When 
the primed RhcE was incubated in the presence of 2,3-DHB, ATP and DhbE, the coupled 
transfer of the DhbE-activated 2,3-DHB to the free thiol group of the ppan arm occurred, 
suggesting the biochemical cross-talk between the two proteins, that are encoded in two 
distantly-located genome regions. 
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4.4 Biochemical characterization of L-Orn tailoring enzymes 
4.4.1 Biochemical characterization of Rmo L-Orn Monooxygenase 
4.4.1.1 Bioinformatic analysis of the NMO Rmo 
In the previous section, it has been demonstrated that rmo encodes for a putative L-
Orn monooxygenase which is involved in the biosynthesis of rhodochelin, since its 
deletion from the chromosome resulted in an abolished siderophore production.  
A bioinformatic analysis showed that Rmo belongs to the class of NAD(P)H/FAD-
dependent monooxygenases and, when compared to already characterized 
homologues (CchB, EtcB, PvdA, SidA, and IucD), it displays high similarity along 
the overall sequence.88,94,178-181 As depicted in the multiple sequence alignment shown 
in Figure 4.12, highly conserved motifs involved in substrate, NADPH, and FAD 
binding could be easily identified. The FAD cofactor-binding consensus GxGxxN is 
located at the N-terminus region of the protein in a conserved dinucleotide-binding 
βαβ-motif. A similar α/β-nucleotide-binding architecture is responsible for the 
binding of the NADPH cosubstrate, enclosed in a similar GxGQS motif. Lastly, the 
residues involved in binding the L-Orn substrate are located in a small domain 
located at the interface between the largest FAD and NADPH binding motifs (an 
homology model is presented in Figure 5.5)15,182 
4.4.1.2 Recombinant production and purification of active apo-Rmo 
rmo was amplified from the R. jostii RHA1 chromosome and cloned into the 
pET28a(+) expression vector. The recombinant protein was heterologously 
produced in E. coli as an N-terminal His-tag fusion and purified via Ni-NTA affinity 
chromatography. UV-vis spectroscopy analysis of the purified recombinant enzyme 
indicates Rmo to be in the apo form, without bound FAD cofactor (Figure 4.13).  
Analytical size exclusion chromatography estimated the molecular mass of Rmo in 
solution to be equal to 220 kDa, suggesting the enzyme to adopt a tetrameric 
quaternary structure, as previously reported for SidA and PvdA (Figure 4.14).178,179  
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Figure 4.12 Multiple sequence alignment of different NMO homologous to Rmo (R. jostii) 
carried out by using the Clustal Omega algorithm.161 The alignment includes: CchB (S. 
coelicolor, 48.2% sequence identity/61.6% sequence homology),88 EtcB (S. erythraea, 
50.9%/64.4%),94 PvdA (Pseudomonas aeruginosa, 35.4%/51.3%),178 AmcK (Amycolatopsis 
sp. AA4, 50.7%/63.2%),183 SidA (A. fumigatus, 34.0%/47.8%)179 and IucD (E. coli EN222, 
25.5%/43.1%).181 All proteins display substrate preference towards L-Orn, except for IucD 
(L-Lys). The degree of conservation is indicated by color: red indicates high and blue no 
agreement. According to Olucha et al.,15 the residues involved in FAD cofactor binding are 
highlighted in yellow, the NADPH cosubstrate in orange and the amino acid substrate in 
green (dark green for the L-Lys coordinating residues in IucD). 
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Figure 4.13 (A) Comassie blue staining of the SDS-PAGE of purified recombinant Rmo. (B) 
UV-vis spectra comparison between equimolar solutions of Rmo and free FAD. Typical 
absorption maxima for FAD are 370 and 450 nm. 
 
Figure 4.14 Analytical size exclusion chromatography of recombinant Rmo. (A) Column 
calibration curve: the gel-phase distribution coefficient Kav was calculated and plotted as a 
function of the logarithm of protein molecular mass. Aldolase (Al, 158 kDa, elution volume 
1.62 mL), ovalbumin (Ov, 43 kDa, elution volume 1.83 mL), ribonuclease (Rb, 13.7 kDa, 
elution volume 2.22 mL) and aprotinin (Ap, 6.5 kDa, elution volume 2.43 mL) were used as 
standards. (B) Size-exclusion chromatogram of 50 μM Rmo displays an elution volume 1.49 
mL, indicative of protein with an apparent molecular mass of 220 kDa. This result suggest 
Rmo to adopt a tetrameric quaternary structure, similar to the homologues SidA and 
PvdA.178,179 
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4.4.1.3 Biochemical characterization of Rmo 
To investigate if Rmo is able to catalyze the conversion of L-Orn to L-hOrn, substrate 
and enzyme were incubated in the presence of the NADPH cosubstrate and the 
FAD cofactor. After a 4 h incubation and in the presence of the enzyme and 
molecular oxygen, HPLC-MS analysis revealed 65% conversion of L-Orn (tR 12.1 
min, m/z 133.1 [M+H]+ observed, m/z 133.1 [M+H]+ calculated) to L-hOrn (tR 19.4 
min, m/z = 149.1 [M+H]+ observed, m/z 149.1 [M+H]+ calculated, Figure 4.15). The 
identity of the enzymatic product of the reaction was verified by comparing its 
retention time and MS-spectra with the synthetic L-hOrn standard (data not shown) 
and, furthermore via HR-MS analysis (m/z 149.0916 [M+H]+ observed, 149.0921 
[M+H]+ calculated). Besides, if in the reaction mixture Rmo or NADPH were 
omitted, the turnover of the substrate into the product was not observed. 
 
Figure 4.15 Rmo-mediated L-Orn hydroxylation. (A) HPLC-MS single-ion chromatogram (SIC) 
of the hydroxylation assays is shown: in the presence of the L-Orn substrate and the reducing 
cosubstrate NADPH, Rmo catalyzes the conversion of L-Orn to L-hOrn (blue trace). The 
control reactions evidence that Rmo is unable to hydroxylate D-Orn (red trace) and that the 
reaction does not proceed if either NADPH or the enzyme is missing (green and purple 
traces, respectively). (B) Chemical structures and observed ESI-MS spectra of the L-Orn 
substrate and the L-hOrn product. 
To evaluate the substrate specificity of Rmo, the enzyme was incubated with a set of 
different amino acids and analyzed as described. Rmo displays an exclusive 
preference towards L-Orn as substrate and NADPH as reducing cosubstrate (Table 
4.2). 
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Table 4.2 Overview of the evaluated substrate specificities for the Rmo-mediated L-Orn 
hydroxylation. 
substrate m/z [M+H]+ 
substrate 
m/z [M+H]+ 
expected 
hydroxylation 
m/z [M+H]+ 
observed 
hydroxylation 
L-Orn 133.1 149.1 149.1 ✔ 
D-Orn 133.1 149.1 133.1 ✖ 
L-fOrn 161.1 177.1 161.1 ✖ 
L-Lys 147.1 163.1 147.1 ✖ 
L-Glu 148.1 164.1 148.1 ✖ 
L-Gln 147.1 163.1 147.1 ✖ 
L-Val 118.1 134.1 118.1 ✖ 
L-Arg 175.1 191.1 175.1 ✖ 
L-Orn (NADH) 133.1 149.1 133.1 ✖ 
 
Kinetic parameters for Rmo-mediated L-Orn hydroxylation were determined 
monitoring the product formation and plotting the starting velocity of the reaction 
as a function of the increasing substrate concentration. The kinetic parameters were 
determined using a Michaelis-Menten equation plot and were calculated to an 
apparent KM = 1.6 ± 0.2 mM and kcat = 0.2331 ± 0.008 s-1, resulting in a catalytic 
efficiency of kcat/KM = 0.15 s-1 mM-1 (Figure 4.16).  
 
Figure 4.16 Michaelis-Menten kinetics for Rmo. NADPH concentration was fixed at 500 μM, 
FAD at 20 μM and Rmo at 5 μM. L-Orn substrate concentration was varied between 0.10 and 
20 mM. Error bars represent standard deviations from three independent measurements. 
In conclusion, Rmo represents a typical member of the NADPH/FAD-dependent 
monooxygenases required for the δ-N-hydroxylation of L-Orn or L-Lys side chains 
associated with the biosynthesis of hydroxamate-type siderophores.15  
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4.4.2 Biochemical characterization of the Rft L-hOrn formylatransferase 
4.4.2.1 Bioinformatic analysis of Rft and other homologous formyltransferases 
Similar to rmo, rft is essential for rhodochelin biosynthesis. A bioinformatic analysis 
showed that Rft exhibits an overall sequence conservation compared to the 
proposed formyltransferases CchA and AmcP, putatively involved in the 
generation of the formyl-derived iron-coordinating hydroxamate moieties in 
coelichelin and amychelin, respectively.13,183 Additionally, the sequence homology 
also extendes to the N-terminal domain of ArnA (a bifunctional enzyme required 
for the generation of a lipid A analogue essential for polymixine resistance in 
Escherichia and Salmonella spp.) and to the endogenous and essential bacterial 
methionyl-tRNAfMet-formyltransferase.184,185 In a derived phylogenetic tree, these 
sequences clearly clusters into different clades, according to their different substrate 
specificities (Figure 4.17). 
 
Figure 4.17 (A) Multiple sequence alignment of Rft’s (R. jostii RHA1) closest homologues. The 
alignment includes: the L-hOrn formyltransferases CchA (S. coelicolor, 66.1% sequence 
identity/81.3% sequence homology)88 and AmcP (Amycolatopsis sp. AA4, 62.2%/80.0%),183 
the N-terminal domain (res. 1-317) of ArnA (E. coli, 30.3%/45.0%)184 and the endogenous 
methionyl-tRNAfMet-formyltransferases (Fmt) of R. jostii (RHA1_fmt, 24.7%39.4%) and E. coli 
(Ecoli_fmt, 30.1%/48.1%).124,185 The degree of conservation is indicated by color: red 
indicates high and blue no agreement. Residues involved in the N10-fH4F cosubstrate binding 
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are highlighted in yellow (SLLP motif), while the catalytic triad (Asn, His, Asp) is shown in 
green. (B) Phylogenetic tree derived from the alignment: the sequences cluster into different 
clades, according to their different substrate specificities: methionyl-tRNAfMet for Fmt, UDP-4-
amino-4-deoxy-L-arabinose (UDP-L-Ara4N) for ArnA and L-fhOrn for Rft, CchA and AmcP. 
Additionally, Rft shares a bimodular organization with the above-mentioned 
enzymes (Figure S8).186 The N-terminal subdomain displays typical elements for 
tetrahydrofolate binding enzymes: the catalytic Asn, His, Asp triad, and the N10-
fH4F “SLLP” binding motif.  
 
Figure 4.18 Multiple sequence alignment of the N-terminal catalytic formyltransferase 
domain carried out by using the MUSCLE algorithm.162 Identity between Rft and the others 
sequences is indicated as follows: 68.2% CchA,88 64.8% AmcP,183 57.9% FxbA (exochelin L-
hOrn formyltransferase M. smegmatis),188 12.8% PvdF (pyoverdine L-hOrn formyltransferase 
P. aeruginosa),189 31.3% ArnA,184 16.9% LgrA_m1 (formylation domain of the initiation 
module of linear gramicidin, B. brevis),80 24.6% Ecoli_purN (glycinamide ribonucleotide 
formyltransferase, E. coli),190 21.9% RHA1_purN (glycinamide ribonucleotide 
formyltransferase, R. jostii RHA1), 27.1% RHA1_fmt and 29.8% Ecoli_fmt.124,185 Residues 
involved in the N10-fH4F cosubstrate binding are highlighted in yellow (SLLP motif), while the 
catalytic triad (Asn, His, Asp) is shown in green. The degree of conservation is indicated by 
color: red indicates high and blue no agreement. 
These conserved residues are also found in the formyltransferases FxbA and PvdF 
(associated with the biosynthesis of L-fhOrn in exochelin and pyoverdine systems), 
the N-terminal formylation domain of the initiation module of the linear 
gramicidine NRPS LgrA, and the glycinamide ribonucleotide formyltransferases 
(GARF) family proteins, although in this latter case, additional structural differences 
and less sequence homology have already been reported (Figure 4.18).80,185,187-189  
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On the other hand, the overall sequence homology between Rft and its above-
discussed closest homologues decreases through the C-terminal subdomain, which 
seems not to be involved in catalysis and, as demonstrated for the methionyl-
tRNAfMet-formyltransferase, could be associated with proper substrate recognition.187 
4.4.2.2 Biochemical characterization of Rft and CchA L-hOrn formyltransferases 
In order to investigate the role of Rft in L-fhOrn biosynthesis, the corresponding 
gene was amplified and cloned in the pET28a(+) expression vector. The 
recombinant protein was purified as an N-terminal His-tag fusion and tested for in 
vitro activity (Figure 4.19).  
 
Figure 4.19 Comassie blue staining of the SDS-PAGE of purified recombinant Rft and CchA. 
The required N10-fH4F cofactor was generated in situ from its N5,N10-methenylH4F 
intermediate, through a 30 min preincubation in the assay buffer (Figure 4.20).151,191 
In the presence of L-hOrn and N10-fH4F, Rft was able to transfer the formyl group 
from the donor cosubstrate to the side chain of the hydroxylated amino acid. After a 
4 h incubation, HPLC-MS analysis revealed 55% conversion of L-hOrn (tR 18.9 min, 
m/z 149.1 [M+H]+ observed, m/z 149.1 [M+H]+ calculated) to L-fhOrn (tR 12.9 min, 
m/z = 177.1 [M+H]+ observed, m/z 177.1 [M+H]+ calculated; Figure 4.21). L-fhOrn 
identity was confirmed by HR-MS analysis (m/z 177.0871 [M+H]+ observed, 
177.0870 [M+H]+ calculated). No conversion was observed in the absence of enzyme 
or cosubstrate. In addition, in similar assay conditions, Rft is unable to formylate L-
Orn or both L-Orn and L-hOrn if N5-fH4F was used as the donor cofactor (data not 
shown). 
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Figure 4.20 (A) Reaction scheme for the in situ generation of the N10-fH4F cofactor. (B) The 
chemical structures and the observed MS-spectra of the ESI-MS measurements of the N5-fH4F 
and the N5,N10-methenylH4F reaction intermediate were carried out to evaluate the complete 
conversion of the substrate after 4h of incubation. 
 
Figure 4.21 Rft- and CchA-mediated L-hOrn formylation. (A) Lower traces: HPLC-MS single-
ion chromatogram (SIC) of the formyltransferase reaction assay is shown: in the presence of 
the L-hOrn substrate and the in situ generated N10-fH4F formyl-donor cosubstrate, Rft 
catalyzes the conversion of L-hOrn to L-fhOrn (blue trace). Control reactions were carried 
out in the absence of the donor cosubstrate or the enzyme (green and light blue traces, 
respectively). Upper traces: a similar assay performed in the presence or the absence of CchA 
(red and orange traces, respectively) rescues the enzymatic activity of this Rft homologue 
from the coelichelin biosynthesis gene cluster, which was previously reported to be 
inactive.13,88 (B) Chemical structures and observed ESI-MS spectra of the L-hOrn substrate and 
the L-fhOrn product. 
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Previous attempts to characterize Rft using the N10-fH4F cosubstrate generated via a 
chemoenzymatic synthesis approach (chemical conversion of H4F to N5,N10-
methyleneH4F in the presence of formaldehyde, followed by a FolD-catalyzed 
regiospecific oxidation/cyclohydrolyzation) always resulted in no detectable 
enzymatic activity (data not shown).192 Similar results were obtained during the 
characterization of CchA, which left unclear whether the enzyme was purified in a 
soluble but inactive form or was rendered inactive by the incubation in the reaction 
assay.88 Therefore, on the basis of the obtained results for Rft, CchA was expressed, 
purified (Figure 4.19), and assayed for enzymatic activity. As shown in Figure 4.21, 
CchA was able to catalyze the conversion of L-hOrn to L-fhOrn (75% after 4 h 
incubation). 
 
Figure 4.22 (A) Sigmoidal plot of Rft kinetic characterization. N5,N10-methenylH4F 
concentration was fixed at 1.5 mM, while L-hOrn substrate concentration was varied 
between 0.25 and 15 mM. Error bars represent standard deviations from three independent 
measurements. (B) In order to elucidate the origin of this unusual cooperative behavior, 
analytical size exclusion chromatography of 50 μM Rft solution was carried out. Rft displays 
an elution volume 1.60 mL, indicative of protein with an apparent molecular mass of 146 
kDa, suggesting the enzyme to adopt a tetrameric quaternary structure, likewise Rmo. The 
calibration curve for the analytical gel filtration is shared with the analytical gel filtration of 
the Rmo monooxygenase, which is illustrated in Figure 4.14. 
The kinetic parameters of Rft tranformylation were determined monitoring the 
conversion of substrate to product and plotting the starting velocities as a function 
of the increasing substrate concentration. Surprisingly, the experimental data could 
be fitted best using a sigmoidal curve, indicative of an allosteric kinetic mechanism, 
rather than the typical rectangular hyperbola characteristic of classical Michaelis-
Menten kinetics (Figure 4.22 A).193 Normalized parameter values were calculated 
through the nonlinear Hill-fit regression and were found to be equal to a Vmax = 
0.078 ± 0.001 μmol L–1 s–1, a K0.5 = 1.2 ± 0.1 mM, and n = 2.7 ± 0.2. A value of the Hill 
parameter n greater than 1 is indicative of a positive cooperative mechanism. To 
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further clarify the origin of this cooperative behavior, analytical size exclusion 
chromatography was employed to elucidate the oligomeric state of Rft.194 As shown 
in Figure 4.21 B, the estimated molecular weight of Rft was 146 kDa, suggesting the 
enzyme to adopt a tetrameric quaternary structure in solution. 
4.4.3 L-fhOrn coupled enzymatic biosynthesis  
To verify whether Rmo and Rft were able to act in tandem to generate L-fhOrn from 
the L-Orn substrate, a similar assay to the Rft-dependent L-hOrn transformylation 
was set up, where first the N10-fH4F cosubstrate was generated in situ, followed by 
the addition of all the remaining components needed for the enzymatic tandem 
conversion to L-fhOrn. Comparison of HPLC-MS traces showed the substrate 
conversion to the L-hOrn intermediate and the L-fhOrn product if both enzymes 
were present or, as expected, only to L-hOrn if Rft was omitted. On the other hand, 
if Rmo was missing, no substrate conversion was observed (Figure 4.23).  
 
Figure 4.23 HPLC-MS single-ion chromatogram (SIC) of the coupled enzymatic biosynthesis 
of L-fhOrn from its L-Orn precursor in the presence of the Rmo monooxygenase and the Rft 
formyltransferase (blue trace). If Rft is omitted, the reaction stops generating only the L-hOrn 
intermediate (red trace); if Rmo is excluded, no conversion at all is observed (green trace). 
Taking all these results of the biochemical characterization of the L-Orn tailoring 
enzymes Rmo and Rft together, it can be stated that both enzymes constitute an 
enzymatic pathway for the biosynthesis of the L-fhOrn building block required for 
the NRPS-dependent rhodochelin assembly. 
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5.1 Isolation and structural characterization of the siderophore rhodochelin 
5.1.1 Rhodococcus spp. as a new source for secondary metabolites 
In recent years, the increasing amount of sequenced microbial genomes has revealed 
the presence of an impressive number of secondary metabolite gene clusters, most 
of them considered “orphan” with respect to their natural product.44 Furthermore, 
since the discovery of the capability of single strains to produce many natural 
products, the concept “One Strain - MAny Compounds” (OSMAC) has been 
introduced; thus, the interest to uncover new secondary metabolites in known 
species is increasing.108 Despite the use of genome mining and its successful 
application, the identification of new natural products still remains challenging. In 
fact, without any experimental proof, it is difficult to define if an orphan cluster is 
silent because it is not functional, the metabolite cannot be detected due to analytical 
detection limits, or the laboratory cultivation methods are inappropriate for its 
biosynthesis.43 
The continuous interest in the Rhodococcus genus as a bioremediation and 
bioconversion tool has shifted the focus to regard these species as natural product 
producing strains.123 As streptomycetes, rhodococci belong to the actinomycetal 
order and thus are predisposed to a putative and underestimated secondary 
metabolism. In addition, they also offer experimental advantages that could ease the 
comprehension of the physiology of closely related species like Mycobacterium and 
Streptomyces, that are difficult to cultivate. Therefore, the complete genome sequence 
of R. jostii RHA1 provides an excellent opportunity that facilitate both the 
exploitation of the catabolic versatility of these industrially-important 
microorganisms and natural product discovery.124 So far, the only secondary 
metabolites isolated from Rhodococcus spp. were the siderophores heterobactin A, 
rhodobactin and the ribosomally-derived lasso peptide lariatin.125,126,195 In addition, 
with the exception of lariatin, the two siderophores still remain orphan with respect 
to their biosynthetic gene clusters.196 
Genome analysis of the R. jostii RHA1 chromosome identified 23 secondary 
metabolite gene clusters, suggesting the possibility of an extensive secondary 
metabolism (Table 5.1).124,157 Most of them encode for peptides of non-ribosomal 
origin, though PKS and hybrid PKS-NRPS systems are present as well. Moreover, 
six of the NRPS genes extent more than 25 kbp in length.168 
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Table 5.1 Secondary metabolite gene clusters in R. jostii RHA1. The list updates the 
prediction described by Nett et al. using the ANTIsmash bioinformatic tool.157,168 
no. cluster location predicted product 
1 RHA1_ro00071-ro00073 NRP 
2 RHA1_ro00136-ro00148 NRP 
3 RHA1_ro00232-ro00235 NRP 
4 RHA1_ro00429-ro00435 NRP 
5 RHA1_ro01106-ro01115 Terpene 
6 RHA1_ro01305-ro01307 Ectoine 
7 RHA1_ro02207-ro02310 PK-NRP hybrid 
8 RHA1_ro02318-ro02323 rhodochelin 
9 RHA1_ro02391-ro02397 NRP 
10 RHA1_ro02492-ro02494 NRP 
11 RHA1_ro04063-ro04066 Polyketide 
12 RHA1_ro04230-ro04231 Polyketide 
13 RHA1_ro04382 ε-poly-L-lysine197 
14 RHA1_ro04612-ro04614 Butyrolactone 
15 RHA1_ro04713-ro04716 NRP 
16 RHA1_ro05093-ro05103 NRP 
17 RHA1_ro05430-ro05431 NRP 
18 RHA1_ro05452-ro05468 NRP 
19 RHA1_ro06098-ro06103 NRP 
20 RHA1_ro06273-ro06307 PK-NRP hybrid / n.a. 
21 RHA1_ro06663-ro06665 NRP 
22 RHA1_ro07030 NRP 
23 RHA1_ro07202-ro07203 Terpene 
 
5.1.2 Isolation and structural characterization of the siderophore rhodochelin  
In this work, the isolation, structural characterization, and genetic and biochemical 
analysis of the biosynthetic origin of the siderophore rhodochelin is reported. The 
siderophore is also known to be the first secondary metabolite isolated from the 
producing strain, R. jostii RHA1. Rhodochelin production was triggered by growing 
the strain in minimal medium, under iron-limited conditions. This resulted in the 
isolation of a CAS-reactive compound that was further purified by HPLC. NMR and 
MSn studies revealed the branched tetrapeptidic structure of the molecule, which is 
composed of a linear assembly of 2,3-DHB, L-Thr, and L-fhOrn. The fourth building 
block (an additional L-fhOrn moiety) is attached to the main tripeptide scaffold 
through an unusual and characteristic ester bond via the side chain hydroxyl group 
of the L-Thr residue. The comparison of the structure of rhodochelin with 
heterobactin A and rhodobactin highlights that the presence of 2,3-DHB and 
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modified ornithine residues is a shared iron-coordinating strategy among the 
different rhodoccocal siderophores isolated so far (Figure 5.1).125,126 
 
Figure 5.1 Chemical structures of heterobactin A, rhodobactin and rhodochelin with 
highlighted iron-coordinating functionalities: 2,3-DHB in red and tailored ornithines in blue. 
Ornithines moieties of heterobactin A and rhodobactin that do not take part in the iron-
coordination are not highlighted. 
Despite the fact that the complete elucidation of the mode and the affinity of the 
ferric-chelation remains to be elucidated, an iron-binding model could be proposed 
(Figure 5.2). Based on the evidence that characteristic UV-vis ligand-to-metal charge 
transfer absorption spectra appear upon the binding of the ferric ion (Figure 4.6), 
both the catecholate and the hydroxamate functionalities take part in the 
coordination.  
 
Figure 5.2 Model of rhodochelin iron-coordination. 
During rhodochelin purification, a second CAS-reactive compound was isolated. 
MS-analysis revealed it to be a rhodochelin degradation product; more precisely it 
was identified as the tripeptide 2,3-DHB-L-Thr-L-fhOrn resulting from the 
hydrolysis of the characteristic ester bond of rhodochelin. This compound was thus 
renamed rhodochelin tripeptide and still retains the ability to complex ferric iron, as 
confirmed via UV-vis spectroscopy and HPLC-MS analysis (Figure S5). 
In principle, after secretion out of the extracellular space, the ferric iron-siderophore 
is selectively and actively imported by specific import systems, different between 
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Gram-positive and Gram-negative bacteria.169,198-201 Thus, as resulting from in vitro 
studies carried out with the holo-rhodochelin and the holo-rhodochelin tripeptide, 
the cognate siderophore binding protein RhcC solely recognizes the ferric-
rhodochelin complex, whereas the ferric-rhodochelin tripeptide does not display 
any affinity for the protein.202 In addition, if purified rhodochelin was incubated at 
room temperature in M9 minimal medium, for a period of time corresponding to 
the growing conditions used for its isolation (~48 h), the spontaneous hydrolysis of 
the ester bond occurs. These results suggest that the hydrolysis of the ester bond 
takes place spontaneously, probably due to the pH of the culture’s medium (Figure 
5.3).  
 
Figure 5.3 Stability assays of rhodochelin solutions. (A) HPLC analysis rhodochelin solution in 
ddH2O, incubated at room temperature for 48 h. (B) HPLC analysis of a rhodochelin solution 
in M9 medium incubated at room temperature for 48 h, revealing the spontaneous 
hydrolyzation of rhodochelin’s ester bond occurs. 
Similarly, the isolation of siderophore analogues that differ from the main molecule 
by the hydrolysis of a specific bond was already reported for fuscachelin and 
heterobactin,125,203 supporting the hypothesis that spontaneous hydrolyzation can 
occur under laboratory growing conditions. Unfortunately, no additional 
investigations were carried out or discussed. It cannot be excluded that the ferric-
rhodochelin tripeptide retains a biological function and is imported into the 
intracellular space by an alternative system. 
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5.2 The biosynthesis of rhodochelin requires NRPS cross-talk 
5.2.1 Identification of the gene set associated with rhodochelin biosynthesis 
The complete set of gene clusters for the biosynthesis of rhodochelin was identified 
by a genome mining approach. The rhc cluster (cluster A) contains the complete 
bimodular NRPS synthetase rhcB, the genes involved in rhodochelin export and 
import (rhcC, rhcD, and rhcF) and two additional ORFs (rhcA and rhcE), homologues 
to the two distinct domains of DhbB, ICL, and ArCP, respectively (Figure 4.7).204 
Interestingly, the first three genes of this cluster (rhcA, rhcB, and rhcC) have 
previously been annotated to belong to an orphan siderophore gene cluster.168 
The presence of 2,3-DHB within the rhodochelin structure led to the investigation of 
the R. jostii RHA1 genome to identify all the genes involved in the biosynthesis of 
the aryl moiety.176 One of the enzymes, an isochorismatase, has already been found 
to be encoded in the rhc cluster (rhcA). Since the biosynthesis of the aryl-capped 
siderophore bacillibactin requires the activation of 2,3-DHB by the stand-alone A-
domain DhbE prior to NRPS-catalyzed assembly, a gene homologous to dhbE 
(cluster C) was identified in a different genomic region, along with two other genes 
involved in 2,3-DHB biosynthesis, namely dhbC and dhbA.35,175 These three genes are 
arranged in an operon-like way and, together with rhcA, cover the entire 2,3-DHB 
pathway, from the chorismate precursor to its activation as adenylate. 
Table 5.2 Substrate specificity prediction for the adenylation domains of the putative NRPS 
RHA1_ro04715. An overview of the modular organization of the synthetase is presented in 
Figure 4.8. The first adenylation domain possesses the same specificity-conferring code found 
in the first A-domain of CchH, involved in coelichelin biosynthesis,13,88 suggesting that also 
RHA1_ro04715 activates L-fhOrn instead of the predicted L-Orn. Variations in the consensus 
are highlighted in red. 
A-domain active site residues substrate product 
4715-A1 DINYWGGIGK   
Coe-A1 DINYWGGIGK L-Orn coelichelin 
4715-A2 DVLHSSLVDK   
ArfB-A4 DVWHMSLVDK L-Ser arthrofactin 
4715-A3 DMENLGLINK   
Ery-A3 DMENLGLINK L-hOrn erythrochelin 
4715-A4 DVFILGAVNK   
Ery-A4 DVFALGAVNK L-haOrn erythrochelin 
 
It is important to note that an additional putative siderophore gene cluster has been 
identified in the R. jostii RHA1 genome (cluster B, Figure 4.7, no. 15 in Table 5.1). 
Because of the overall homology of the tetramodular NRPS RHA1_ro04715 with 
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EtcD14,169 (supported by the comparison of the adenylation domain substrate 
specificity prediction, and the contextual presence of two tailoring enzymes Rmo 
and Rft), it is suggested that this cluster could be responsible for the synthesis of a 
foroxymithine/erythrochelin analogue (Figure 5.4).170 Bioinformatic analysis of the 
NRPS RHA1_ro04715 revealed that the first adenylation domain possesses the same 
specificity-conferring code found in the first A-domain of CchH, involved in 
coelichelin biosynthesis (Table 5.2),13,88 suggesting that RHA1_ro04715 also activates 
L-fhOrn as a cognate substrate, which is subsequently incorporated into the putative 
natural product. 
 
Figure 5.4 Comparison of the chemical structures of erythrochelin14 (S. erythraea NRRL2338) 
and foroxymithine170 (Streptomyces nitrosporeus) reveals a high degree of structural 
similarity; the molecules differ in the stereochemistry of the first two amino acids and the 
tailoring of the hydroxyornithine sidechain of the first and the last amino acid (acetylation is 
highlighted in blue, formylation in red). On the right, the structure of the putative product of 
the NRPS RHA1_ro04715 is presented. The structure is based on both the modular 
organization of the NRPS (Figure 4.8) and the A-domains substrate specificity prediction 
(Table 5.2), implying a similar assembly strategy like the one proposed for erythrochelin.14,169 
According to the results of the genome mining, the existence of three distantly 
located gene clusters involved in rhodochelin assembly was proposed. This 
hypothesis was verified employing a gene disruption approach, showing that single 
key gene deletions in different clusters (rhcB, dhbE, rmo, and rft were targeted) were 
sufficient to inhibit siderophore biosynthesis, and that the dispersed genes along the 
three clusters are equally required for the biosynthesis of rhodochelin.  
5.2.2 Genome comparison between sequenced Rhodococcus strains 
Genome comparison of R. jostii RHA1 with other sequenced Rhodococcus strains 
revealed that only the closely-related Rhodococcus opacus B4205,206 shares an identical 
gene arrangement within all the three gene clusters associated with rhodochelin 
biosynthesis. The RhcB NRPS synthetase and its R. opacus B4 homologue revealed 
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100% identity for the A-domain specificity-conferring codes, suggesting that also 
rhodochelin is the endogenous siderophore of the latter strain (Table S3). 
Interestingly, the additional sequenced strains analyzed (Rhodococcus equii 103S207 
and R. erythropolis PR4) share the contextual presence of cluster B and cluster C, 
despite the presence of minor genetic rearrangements (gene integrations and 
deletions, Table S4). 
Table 5.3 Comparison of the adenylation domains substrate specificity predictions for the 
cryptic NRPS RHA1_ro04715 in the other Rhodococcus strains analyzed. Variations in the 
consensus are highlighted in red. 
strain % id./sim. A1 – L-fhOrn A1 – L-Ser A3 – L-hOrn A4 – L-haOrn 
R. jostii RHA1  DINYWGGIGK DVLHSSLVDK DMENLGLINK DVFILGAVNK 
R. opacus B4 91 / 95 DINYWGGIGK DVLHSSLVDK DMENLGLINK DVFILGAVNK 
R. equii 103S 68 / 78 DINYWGGIGK DVPHASLVEK DMENLGLINK DVFILGAVNK 
R. erythropolis PR4 65 / 77 DINYWGGIGK DVPHNSLVDK DMENLGLINK DVFILGAVNK 
 
In addition, similar results were also obtained for the cryptic NRPS RHA1_ro04715, 
which displayed high sequence similarity among all the homologues in the three 
strains analyzed (Table 5.3). As shown in Figure 5.4, the putative product of the 
NRPS RHA1_ro04715 only includes hydroxamate iron-coordinating functionalities, 
while rhodochelin contains both catecholate and hydroxamate groups. Catecholates 
are known to bind iron more tightly than hydroxamates.10 This would lead to a 
siderophore with increased iron-binding affinity, providing an evolutionary 
advantage to the organism’s capability to thrive under iron-limited conditions. A 
second possible explanation is that the evolution of an alternative siderophore (with 
mixed iron-coordinating functionalities) could confer an additional selective 
advantage due to the fact that siderophore uptake systems usually employ receptors 
capable of recognizing only certain types of ferric-siderophore complexes. This 
would results in a situation where less competing organisms would be able to hijack 
the iron-loaded siderophore in question.208,209 
5.2.3 Genome cluster cross-talk associated with the production of microbial 
secondary metabolites 
Usually the genes required for the biosynthesis of secondary metabolites are 
clustered together within one chromosomal locus, allowing their coordinated 
expression and regulation.210,211 This concept, together with the increasing number of 
sequenced genomes, accounted for the successful development of different 
strategies aimed for successful new natural product discovery.43,212 The hypothesis 
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that natural product gene clusters are among the most diverse and rapidly-evolving 
genetic elements of a bacterium’s chromosome has been recently proposed, 
suggesting them to be the ideal candidates for the evolutionary study of bacterial 
collectives.213 In this context, the discovery of different examples of cross-talk 
mechanisms between the secondary metabolite gene clusters can be representative 
of the bacterium’s genome plasticity towards the natural selective pressure, 
continuously remodeling its elements (and thus its metabolome), fueling the fitness 
for the environment. 
Similarly to rhodochelin, the catecholate siderophore vibriobactin (Vibrio cholerae), 
harbors its biosynthetic genes within two different genome regions. The genes for 
the siderophore transport and utilization, viuA and viuB, and the biosynthetic NRPS 
vibF214-216 are separated from those associated with the biosynthesis and activation of 
2,3-DHB and for the periplasmic binding and ABC-dependent intracellular import 
of the iron-siderophore complex.217-219 On the other hand, to our knowledge, 
rhodochelin is the first example where the genes associated with the biosynthesis of 
the aryl moiety are not clustered together.175 Another siderophore, erythrochelin, is 
synthetized by genes dispersed between two diverse gene clusters:14,169 the erc/etc 
cluster encodes the enzymes responsible for precursor biosynthesis and siderophore 
assembly and export, whereas the δ-N-L-acetyltransferase mcd (also essential for the 
biosynthesis of erythromycin and the red pigment flaviolin220) is located in the 
nonfunctional nrps1 cluster.221 Moreover, PPTases, the enzymes responsible for the 
apo- to holo- conversion of carrier protein domains of FAS, PKS and NRPS, are an 
additional example of enzymes being shared by different biosynthetic pathway, 
sometimes displaying a high degree of substrate tolerance towards the carrier 
protein, like B. subtilis Sfp.154,155 
Recently, a few additional examples of functional secondary metabolism cross-talk 
mechanisms have been reported, demonstrating that a more complex biosynthetic 
network exists. For example, either one of two essential malonyl-CoA 
acyltransferases of the endogenous fatty acid synthase complex are required for the 
biosynthesis of the anticancer depsipeptide FK288 in Chromobacterium violaceum 968, 
since the two modules DepB and DepC of the PKS lacks the essential AT function 
which is replaced by an AT-docking domain. Additionally, in the same species, the 
activation of the FK288 PKS ACP domains requires a broad-substrate-range Sfp-
type PPTase which is encoded in a different locus.222 Similar to the last discussed 
example, the initiation reaction of the assembly of the quinoxaline antibiotics 
requires the transfer of the activated chromophore quinoxaline-2-carboxylic acid 
from the cognate stand-alone A-domain TrsI to the first elongation NRPS TrsII. This 
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step is carried out by an ACP from the primary FAS II, to form an initiation module, 
showing a functional interaction between the primary and the secondary 
metabolism.49 
Cross-talk between different secondary metabolites gene clusters can also occur on 
the regulatory level. For example, in P. fluorescens Pf-5, phloroglucinol act either as a 
precursor, an inducer and a repressor of the biosynthesis of the antibiotics 
pyoluteorin and 2,4-diacetylphloroglucinol. At nanomolar concentration, the 
presence of the 2,4-diacetylphloroglucinol precursor phloroglucinol is required to 
stimulate the biosynthesis of pyoluteorin, which is inhibited at higher 
concentrations.223 Another similar cross-talk mechanism has also been observed in 
fungi. In Aspergillus nidulans, the overexpression of a putative pathway-specific 
NRPS-regulatory gene scpR induces the activation and, thus, the formation of a 
cryptic NRP, which further downstream upregulates a second transcription factor, 
afoA. This latter one activates the biosynthesis of the polyketide asperfuranone 
through its specific biosynthetic pathway. In addition, these results represent the 
first report of regulatory cross-talk between two biosynthetic gene clusters located 
on different fungal chromosomes.224 
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5.3 Biosynthesis of the non-proteinogenic amino acid L-fhOrn  
The use of hydroxamate groups as iron-coordinating moieties is a shared strategy 
employed by both NRPS-dependent and NRPS-independent pathways for 
siderophores biosynthesis.20 In both cases, it generally requires the hydroxylation of 
the lateral amino group of a basic amino acid (lysine or ornithine), followed by the 
additional transfer of an acetyl or formyl group to the secondary amine 
intermediate, generating the functional hydroxamate moiety. This building block is 
subsequently incorporated by the NRPS-dependent or NRPS-independent assembly 
enzymes into the siderophore peptide scaffold.15,26  
5.3.1 Characterization of the L-Orn monooxygenase Rmo 
On the basis of a bioinformatic analysis, Rmo was predicted to belong to the N-
hydroxylating flavoprotein monooxygenases (NMO), of whom different 
homologues have previously been characterized through extensive biochemical and 
structural studies. 88,94,178-181,225  
 
Figure 5.5 The comparison between the crystal structure of the P. aeruginosa L-Orn 
monooxygenase PvdA (PDB code: 36S1, A) and the I-TASSER226 structure prediction of Rmo 
(B, prediction C-score 0.90). The FAD-binding domain is colored in blue, the NADPH-binding 
domain in red and the L-Orn binding domain in yellow. The catalytic pocket is located at the 
interface of the three domains. In the PvdA structure FAD, NADPH and L-Orn are shown as 
CPK-colored sticks.  
In a multiple sequence alignment, Rmo shares a high degree of sequence identity 
with the aforementioned homologues, especially around the sites involved in the 
coordination of the substrates and the FAD cofactor. In model prediction, the Rmo 
structure reflects the overall characteristic three-domains folding of the PvdA’s 
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crystal structure (Rmo homologue from P. aeruginosa, Figure 5.5). The NADPH-
binding domain is inserted within the largest FAD-binding domain and the active 
site pocket is formed between the two and the opposite smallest L-Orn binding 
domain.182 Spectrophotometric analysis of the recombinant enzyme confirmed Rmo 
to be purified in the apo form, without bound FAD cofactor. Again, according to the 
crystal structure of PvdA, the FAD binding site is located in close proximity to the 
surface of the enzyme. Therefore, the loss of the flavin cofactor during purification is 
not unexpected.182 In the presence of molecular oxygen, NADPH and FAD, the Rmo 
monooxygenase was able to convert L-Orn into L-hOrn. As other members of the 
NMO family, Rmo shows an exclusive preference toward its cognate amino acid 
substrate and the reducing cosubstrate NADPH. In addition, similar to SidA and 
PvdA, Rmo adopts a tetrameric quaternary structure in solution, which does not 
alter the catalytic properties of the single subunits, resulting in classical 
Michaelis−Menten behavior.178,179 When compared with other L-Orn monooxygenase 
homologues, the determined kinetic parameter are in accordance with previously 
published results, despite the fact that Rmo does not possess a similar high catalytic 
efficiency as EtcB or VbsO (Table 5.4).94,225 
Table 5.4 Kinetic parameter for Rmo-mediated L-Orn hydroxylation and comparison with 
others homologues L-Orn monooxygenases involved in siderophore biosynthesis. 
enzyme siderophore KM (mM) kcat (s
-1) kcat/KM (s
-1 mM-1) 
Rmoa rhodochelin 1.6 ± 0.2 0.2331 ± 0.008 0.15 
EtcBb,94 erythrocelin 0.286 ± 0.035 0.3267 ± 0.0005 1.14 
CchBb,88 coelichelin 3.6 ± 0.58 0.290 ± 0.01 0.081 
VbsOb,225 vicibactin 0.305 ± 0.024 1.80 ± 0.03 5.90 
PvdAa,178 pyoverdin 0.60 ± 0.07 0.400 ± 0.05 0.67 
SidAa,179 ferrichrome 1.70 ± 0.06 0.4833 ± 0.005 0.284 
SidAa,180 ferrichrome 0.58 ± 0.07 0.611 1.0 
a steady state parameters for hydroxylated product formation. 
b steady state parameters for coupled NADPH oxidation assay.  
 
Extensive kinetic analyses of PvdA and SidA have allowed the postulation of a 
reaction mechanism for the L-Orn hydroxylation (Figure 5.6).180,227 Upon reduction of 
the flavin cofactor by NADPH, the subsequent binding of molecular oxygen results 
into two different intermediates. For PvdA, it is hypothesized to be a peroxyflavin 
which is subsequently converted to the active and long-lived hydroperoxyflavin by 
the donation of a proton from the amino group of the substrate side chain.178 For 
SidA, it is a hydroperoxyflavin species that is stabilized by the presence of NADP+. 
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Figure 5.6 Mechanism for the N-hydroxylation flavoprotein monooxygernases based on 
kinetic data for PvdA and SidA.178-180,182,227 
In both cases, the subsequent binding of the L-Orn substrate (which is therefore 
uncoupled from the NADPH oxidation) enhances the rate of formation of the 
reactive hydroperoxyflavin intermediate that donates its distal oxygen to the amino 
group of the L-Orn side chain, giving the L-hOrn product. The cycle ends with the 
dehydration of the hydroxyflavin to flavin (regenerating the cofactor) and the 
dissociation of the L-hOrn and NADP+. 
In conclusion, Rmo represents a typical member of the NADPH/FAD-dependent 
monooxygenases required for the δ-N-hydroxylation of L-Orn or L-Lys side chains 
associated with the biosynthesis of hydroxamate-type siderophores.15 
5.3.2 Characterization of the L-hOrn formyltransferase Rft 
The biochemical characterization of Rft represents the first in vitro study of a 
tailoring formyltransferase involved in the biosynthesis of formyl-based iron-
coordinating hydroxamate moieties. In fact, previous attempts to elucidate the role 
of homologous and analogous enzymes (Ccha, PvdF, and FxbA) were not successful 
or relied on the use of genetic strategies employing indirect detection 
methods.88,188,189 Rtf catalyzes the N10-fH4F-depented formylation reaction of the L-
hOrn intermediate, establishing a route for the L-fhOrn biosynthesis, prior to its use 
by the NRPS assembly line. 
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Figure 5.7 The comparison between the crystal structure of the E. coli methionyl-tRNAfMet-
formyltransferase (PBD code: 2FMT, A) and the I-TASSER226 structure prediction of Rft (B, 
prediction C-score 1.50). The catalytic N-terminal subdomain is colored in green, the C-
terminal subdomain in red; in the E. coli formyltransferase, the latter subdomain is involved 
in the proper recognition and binding of the methionyl-tRNAfMet substrate (blue).187 The SLLP 
motif, required for the coordination of the N10-fH4F cofactor, and the catalytic triad are 
shown as yellow and orange sticks, respectively.  
In contrast to the endogenous methionyl-tRNAfMet-formyltransferase, ArnA, and the 
F-domain embedded within the LgrA initiation module, Rft catalyzes the 
formylation of a secondary amine, whereas the previously mentioned enzymes 
modify a primary amino group.80,184,185 On the basis of the sequence similarities of 
Rft with ArnA and the other N10-fH4F-depented formyltransferases, a mechanism 
for the L-hOrn transformylation reaction is proposed (Figures 5.7 and 5.8).228-231 
His105 and Asn103 activate the carbonyl carbon of the formyl group, which is attacked 
by the secondary amine of L-hOrn (the putative intermediate is stabilized by both 
His105 and Asn103). A water molecule, properly positioned in the active site by the 
Asp141 side chain, mediates the proton transfer from the amine group of the L-hOrn 
side chain to the tetrahydrofolate.232 Subsequently, the reaction ends with the 
decomposition of the tetrahedral intermediate and the release of the L-fhOrn 
product and tetrahydrofolate. The use of an alternative strategy for the generation 
of the unstable, and thus commercially unavailable, N10-fH4F cosubstrate, namely 
the in situ transformation of N5,N10-methenylH4F to the desired N10-fH4F, through 
preincubation in the assay buffer (Figure 5.9), has proved to be successful, resulting 
in enzymatically active cofactor. Likewise, this strategy was applied to the hitherto 
inactive CchA, promoting the conversion of L-hOrn to L-fhOrn, implying a similar 
biosynthetic mechanism for the same iron-coordinating group in the siderophore 
coelichelin.88 
Discussion 
 93 
 
Figure 5.8 Suggested catalytic mechanism for the Rft-dependent L-hOrn transformylation 
reaction, based on the reaction mechanism proposed by Gatzeva-Topalova et al.228 
 
Figure 5.9 (A) Synthesis of the N10-fH4F cofactor via the chemical conversion of the N
5-fH4F 
substrate to the to N5,N10-methenylH4F intermediate. Prior to the addition of the enzyme, the 
preincubation of the intermediate in the reaction buffer (pH 7.5) allows the final conversion 
to N10-fH4F. (B) Chemoenzymatic synthesis of N
10-fH4F. The H4F substrate is spontaneously 
converted to the N5,N10-methyleneH4F intermediate by the addition of formaldehyde. Then, 
the FolD dehydrogenase/cyclohydrolase catalyzes the final conversion to N10-fH4F.
192 Solely 
the first approach generated active N10-fH4F cofactor for the characterization of the L-hOrn 
formyltransferase activities of Rft and CchA.  
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Rft kinetic characterization indicates a positive cooperative effect, possibly resulting 
from the fact that, in solution, the enzyme adopts a tetrameric quaternary structure. 
In this context, the conserved presence of the C-terminal subdomain (which does 
not feature any catalytic residues) could be seen as a modification of the original 
tRNA binding function of the methionyl-tRNAfMet-formyltransferase to an 
oligomerization and/or allosteric role in Rft.187 In addition, the positive cooperative 
control mechanism could improve the overall biosynthesis of the non-proteinogenic 
L-fhOrn amino acid (and thus its incorporation by the NRPS assembly line), 
providing an enhancement for siderophore biosynthesis under the restrictive iron-
limiting growing conditions. Moreover, it is not to be excluded that both Rmo and 
Rft tetramers could undergo an additional oligomerization, raising up a functional 
octamer that further enhance L-fhOrn biosynthesis, in a similar fashion the EntE-
dependent 2,3-DHB adenylation is stimulated by the protein-protein interaction of a 
EntA tetramer.233 
In conclusion, on the basis of the results of the coupled assay and the additional 
inability of Rmo to hydroxylate L-fOrn and of Rft to transformyate L-Orn, a model 
for the biosynthesis of the formyl-based hydroxamate-containing siderophores 
could be proposed, according to the so-called “hydroxylation first” mechanism, 
recently described for the acetyl-based hydroxamates (Figure 5.10).94 Initially, the L-
Orn side chain amino group is hydroxylated by a NMO enzyme, and then the 
newly modified L-hOrn could be either incorporated by the NRPS assembly line 
(coelichelin) or further modified by formylation, leading to the generation of iron-
coordinating L-fhOrn (coelichelin or rhodochelin). 
 
Figure 5.10 Coupled enzymatic biosynthesis of L-fhOrn. Rmo converts L-Orn into L-hOrn. This 
hydroxylated intermediate serves as a substrate for the subsequent N10-fH4F Rtf-catalyzed 
formylation reaction, resulting in the non-proteinogenic L-fhOrn, subsequently incorporated 
in the peptide scaffold by the RhcB NRPS. 
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5.4 Biochemical and genetic model for rhodochelin biosynthesis 
5.4.1 A biosynthetic model for rhodochelin assembly 
The results obtained in this study allow the postulation of a model for rhodochelin 
biosynthesis (Figure 5.11). Rhodochelin assembly is initiated by DhbE, which 
activates 2,3-DHB that is subsequently transferred to its cognate stand-alone aryl 
carrier protein RhcE. RhcB assembles the tripeptide DHB-L-Thr-L-fhOrn following 
the classical linear logic of NRPS assembly lines, similar to the fashion in which the 
tripeptide DHB-L-Gly-L-Thr of bacillibactin is formed.35 From the RhcB-PCP2 the 
newly assembled tripeptide is transferred to the conserved catalytic Ser of the TE-
domain. Subsequently, a second L-fhOrn is proposed to be activated by the 
respective domain (following a module skipping mechanism, similar to coelichelin 
assembly) and tethered to RhcB-PCP2.13 With the tripeptide and the monomer 
residing in adjacent positions, the nucleophilic attack of the hydroxyl group in the L-
Thr side chain on the L-fhOrn thioester could occur. This mechanism is consistent 
with an iterative TE-domain following a “forward” mechanism, like the proposed 
lactonization mechanism of DHB-L-Gly during enterobactin biosynthesis.104 Then, 
the branched tetrapeptide, still attached to the TE, is hydrolytically released and 
exported to the extracellular space to carry out its biological function. 
 
Figure 5.11 Proposed biosynthetic pathway for rhodochelin assembly. The two non-
proteinogenic building blocks 2,3-DHB and L-fhOrn are synthesized by the corresponding 
pathways and channeled to the synthetase RhcB. Prior to the TE-catalyzed release, a second 
L-fhOrn building block is activated, following a “module skipping” mechanism. A detail of the 
ester bond formation between L-fhOrn and the side chain of L-Thr is presented.  
The tripeptide found in the culture supernatant also displays iron-scavenging 
properties (Figure S5). In addition, while it was demonstrated that the hydrolysis of 
the labile ester bond occur spontaneously in the culture medium, with regards to 
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the postulated “forward” mechanism, it cannot be completely excluded that 
rhodochelin tripeptide is the result of the premature release from the TE-domain 
during the assembly of the peptide. 
5.4.2 Putative regulation of the rhodochelin biosynthesis 
In GC-rich Gram-positive bacteria, control of the expression of the genes involved in 
iron metabolism is usually achieved by DmdR (divalent metal-dependent 
regulatory protein). This system was previously known as DtxR, where it was first 
reported to control the expression of the diphtheria toxin gene tox.234 The tox gene 
promoter contains a palindromic consensus that is recognized by a DtxR dimer, 
upon binding of a divalent metal ion (Fe2+, Co2+, Ni2+, Cd2+).235-241 DmdR/DtxR 
homologues were found in M. tuberculosis, Streptomyces pilosus, Streptomyces lividans, 
S. coelicolor, and R. equii. 242-246 In particular, in S. coelicolor, two DmdR homologues 
(namely DmdR1 and DmdR2) were reported to bind the 19-bp iron boxes consensus 
located upstream of the tox and the desA genes, forming two different complexes: 
whereas DmdR1 only forms dimers, DmdR2 is also capable of forming tetramers. In 
addition, seven different iron-boxes were found in ten different locations in the 
genome of S. coelicolor, most of them located upstream of putative genes involved in 
siderophore biosynthesis. Lastly, the comparison of the iron-boxes sequence 
allowed the definition of a consensus for the Streptomyces species 
(TTAGGTTAGGCTCACCTAA).245 
On the basis of this knowledge, two DmdR homologues were identified in the 
genome of R. jostii RHA1. The putative protein product of the ORF RHA1_06810 
displayed 60% sequence identity (73% of sequence similarity) with DmdR1, whereas 
the putative product of the ORF RHA1_ro06652 showed 29% sequence identity (48% 
of sequence similarity), respectively.  
 
Figure 5.12 Comparison between the genomic regions of R. jostii RHA1 and C. diphtheriae 
where the iron-dependent repressor dtxR is located.247 galE is predicted to encode a putative 
UDP-galactose 4-epimerase,248 sigB a sigma transcription factor with homology to σ70-type 
family, ro06811 an acetoin dehydrogenase and ro06812 an acetyl-CoA synthetase. 
In addition, RHA1_06810 is located in a genomic region that displays a similar genic 
organization with respect to the chromosomal locus of C. diphtheriae where dtxR is 
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located (Figure 5.12).247 More interestingly, the use of the S. coelicolor iron-box 
consensus sequence allowed the identification of six different iron-boxes within the 
R. jostii RHA1 chromosome, all located in the three genic cluster responsible for the 
biosynthesis of rhodochelin, approximately 100 bp upstream of the start codon of 
the following genes: rhcA, rhcB, rhcD/rhcE, RHA1_ro04715, rmo and dhbC (Figure 
5.13). Analogously, a putative iron-box consensus for R. jostii RHA1 was proposed 
(TTAGGTTAGGCTANCCTTA). 
 
Figure 5.13 (A) Location of the six iron-boxes within the three rhodochelin gene clusters. The 
sequences were identified using consensus identified using the Virtual Footprint tool of the 
PRODORIC database.249 (B) Multiple sequence alignment of the iron-boxes located upstream 
the rhodochelin biosynthetic genes. The distance to the closest gene is indicated in 
parenthesis. In addition, a putative iron-box consensus for R. jostii RHA1 is proposed 
(TTAGGTTAGGCTANCCTTA).250 
The current results suggest that, similarly to S. coelicolor, an analogous system for 
the global iron-dependent transcriptional regulation could be present in R. jostii 
RHA1.245 Under iron-limited conditions, the absence of the ferrous iron in the 
intracellular space promotes the dissociation of the DmdR repressor dimer from its 
regulatory sequence, allowing the transcription of the genes associated with 
rhodochelin biosynthesis. Five iron-boxes are located directly upstream of all the 
genes responsible for the precursor biosynthesis, the siderophore assembly and its 
subsequent export to and uptake from the extracellular space, while the sixth is 
located upstream the cryptic NRPS gene RHA1_ro04715. Therefore, although the 
cryptic NRPS gene seems to be under the same transcriptional control as the genes 
for rhodochelin’s biosynthesis, the evidence that no product has been detected does 
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not exclude the synthetase to be functional, to be silent (other unknown repressors 
or activators could play a role at a different hierarchical transcriptional level) or the 
growing conditions applied are inadequate to allow detection. On the other hand, 
the absence on the iron-box consensus upstream of the rft gene still does not exclude 
a different transcriptional control, or, that the biosynthesis of the nonproteinogenic 
L-fhOrn amino acid is simply enhanced by the positive cooperative mechanism of 
the Rft tetramer in vivo. 
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5.5 Perspective and outlook 
Microorganisms produces a multitude of small molecules that are not used in the 
primary metabolism but take part in important physiological and ecological roles, 
mediating the interactions among other species of the community and/or with 
multicellular organisms.213 The discovery that the genes responsible for the 
biosynthesis of natural products are often clustered together in a genome facilitated 
the important genetic and the biochemical findings during the last two decades. 
Conversely, the presented discovery of cross-talk mechanisms between three gene 
clusters for the biosynthesis of a single secondary metabolite in R. jostii RHA1,251 
supports an unexpected level of complexity, especially for a molecule with a relative 
simple (but still important) function, like a siderophore. In this context, the 
hypothesis that natural product gene clusters are among the most diverse and 
rapidly evolving genetic elements of a chromosome reflects the genome plasticity 
towards the natural selective pressure, continuously remodeling its elements to best 
fit the environment. In addition, understanding the molecules and the mechanisms 
that microorganism use to interact with each other can lead to a deeper 
understanding of their physiology, ecology and evolution and, lately, to a new and 
better drug discovery for human therapy.252 
The existence of approximately 20 secondary metabolite gene clusters in R. jostii 
RHA1 that remains still orphan with respect to their biosynthesized molecule put 
the strain into account for the isolation and the structural characterization of new 
natural products. Several strategies have already been reported being successful 
and can be employed to elicit cryptic pathways in other species; for example, 
triggering the global nutritional regulators of primary metabolism under phosphate 
or nitrogen starvation253, using of small chemical as elicitors,254 or with the co-
cultivation in the presence of other species of the same ecosystem, in order to 
attempt to simulate the natural habitat and prompt the inter-species 
communication.255 Apart from culture-dependent techniques, the availability of 
different genetic tools specifically designed for Rhodoccocus spp. allows the genetic 
engineering of the strain and thus the identification of new natural products 
through comparative metabolic profiling.44 In particular, the use of plasmid systems 
specifically engineered for heterologous gene expression in Rhodoccocus spp.256 can 
be employed to activate cryptic biosynthetic gene clusters through the inducible 
and/or constitutive manipulation of pathway-specific activators, as recently 
demonstrated for Streptomyces ambofaciens and Burkholderia spp.257-259 
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Supplementary section 
Supporting tables 
Table S1 Table of chemical shifts (ppm) of rhodochelin in H2O/D2O (9:1) at 283 K. 
Position δ13C δ1H (multi, J Hz) δ15N HMBC correlation 
2,3-DHB 1 117.13    
2 146.06    
3 144.68    
4 119.82 7.088 (d: 8.3 Hz)  H4 to C2, C6 
5 119.67 6.876 (t: 8.4 Hz)  H5 to C1, C3 
6 120.12 7.347 (d: 8.8 Hz)  H6 to C2, C4, C7 
7 169.18    
L-Thr1 
1  9.169 (d: 8.6 Hz) 114.4 H1 to C7 (2,3-DHB) 
2 56.15 4.978 (m)  H2 to C5 
3 73.19 5.573 (m)  H3 to C5, C7 (L-fhOrn3) 
4 15.84 1.396 (d: 6.4 Hz)  H4 to C2 
5 169.71    
L-fhOrn2 
1  8.505 (d: 7.5 Hz) 125.0 H1 to C5 (L-Thr1) 
2 54.72 4.19 (m)  H2 to C4, C5 (L-Thr1), C7 
3 27.81 1.77 (m)  H3 to C5 
4 21.70 1.77 (m)  H4 to C2 
5 49.87 3.53 (m)  H5 to C3, C6 
6 159.28 7.893 (s)  H6 to C5 
7 177.71    
L-fhOrn3 
1     
2 52.30 4.131 (m)  H2 to C4 
3 26.51 1.88, 1.69 (m)  H3 to C7 
4 22.63 1.88, 1.69 (m)  H4 to C2 
5 49.34 3.47 (m)  H5 to C3, C6 
6 159.28 7.826 (s)  H6 to C5 
7 168.38    
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Table S2 Bioinformatic overview of the gene clusters involved in rhodochelin biosynthesis. 
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Table S3 Comparison of the RhcB synthetase adenylation domains code between R. jostii 
RHA1 and R. opacus B4. 
strain % id./sim. A1 A2 
R. jostii RHA1  DFWNVGMVHK DLWGMGAVNK 
R. opacus B4 92 / 95 DFWNVGMVHK DLWGMGAVNK 
 
Table S4 Summarizing overview of rhodochelin biosynthetic gene clusters in other 
Rhodococcus strains as found via bioinformatic analysis. 
 Cluster A Cluster B Cluster C 
R. opacus B4 ✔ ✔ ✔ 
R. equii 103S ✖ ✔a ✔c 
R. erythropolis PR4 ✖ ✔b ✔d 
✔ all genes were found in the cluster. 
✔ majority of the genes were found within the cluster (differences are described below). 
✖ gene cluster not found. 
a gene insertion between RHA1_ro04711 and rft homologues; the gene cluster lacks RHA1_ro04714 
homologue. 
b gene insertion between RHA1_ro04713 and RHA1_ro04715 homologues; the gene cluster lacks 
RHA1_ro04714 homologue. 
c presence of rhcA homologue (isochorismate lyase) at the 3' end of the cluster. 
d additional presence of rhcE homologue (aryl carrier protein) located between dhbA and dhbC 
(different genomic orientation). 
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Supporting figures 
 
Figure S1 FT-IR spectrum of rhodochelin. 
 
Figure S2 DQF-COSY spectrum of rhodochelin in in H2O/D2O (9:1) at 283 K. 
  
1000200030004000
32.5
35.0
37.5
40.0
42.5
45.0
47.5
Wave number (cm-1)
%
 T
ra
ns
m
itt
an
ce
17
49
.5
C
=
O
 
es
te
r 
bo
nd
 s
tr
et
ch
ppm
9 8 7 6 5 4 3 2 1 0 ppm
10
8
6
4
2
Supplementary section 
 115 
 
Figure S3 ROESY spectrum of rhodochelin in in H2O/D2O (9:1) at 283 K with mixing time 
300 ms. 
 
Figure S4 HMBC spectrum of rhodochelin in in H2O/D2O (9:1) at 283 K. 
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Figure S5 (A) HPLC-MS profile of the Fe-loaded rhodochelin tripeptide. (B) UV-VIS spectrum 
of 400 μM apo-rhodochelin tripeptide (blue line) and holo-rhodochelin tripeptide (red line). 
 
 
Figure S6 Agarose gel electrophoresis of PCR reactions amplified with external primer pair 
P1/P4, showing the resulting gene deletion compared to the corresponding wild-type strain 
(on the left). Due to the length of rhcB (> 7 kbp), lanes marked with an asterisk were 
amplified with a different primer pair, annealing inside rhcB. 
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Figure S7 Comparison of CAS activity assays of the culture supernatant of wild-type R. jostii 
RHA1 and the deletion strains. 
 
Figure S8 SMART domain analysis and modular organization of the different N10-fH4F-
dependent formyltransferases discussed in the text. 
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